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Thrombosis After Drug-Eluting Implantation     
1026-150·A261
Prevalence and In-Hospital Outcomes of Multivessel PCI 
during Primary PCI for ST-segment elevation myocardial 
infarction: Results from the American College of 
Cardiology National Cardiovascular Data Registry (ACC-
NCDR)     1005-129·A236
Primary Percutaneous Coronary Intervention in Acute 
Myocardial Infarction With or Without Thrombectomy: A 
MetAAnalysis     1012-129·A243
Primary Percutaneous Coronary Intervention Performed 
During Nightshift Hours Was Associated With Increased 
In-Hospital Mortality in Patients With ST Elevation 
Myocardial Infarction: Results From EUROTRANSFER 
Registry     1017-54·A202
Procedural Delay Does Not Explain the Circadian Variation 
Observed in Outcomes of Primary PCI for STEMI: 
Insights From the APEX-AMI Trial     1017-51·A201
Randomized Trial of Early Versus Late Abciximab 
Administration in Patients Undergoing Primary 
Angioplasty: Infarct Size Assessment With Magnetic 
Resonance Imaging: The Myocardial Perfusion Study     
1017-53·A202
Rapid Right Ventricular Pacing Facilitates Transcatheter 
Coronary Stent Implantation to the Ostial Left Anterior 
Descending Artery When Stent Stability Is Not Achieved 
During Stent Positioning     1033-147·A267
Relation of Angiographic Patterns and Ejection Fraction 
to Clinical Outcomes in the COURAGE Trial     
1012-133·A244
Remote Ischemic Preconditioning in Humans Attenuates 
Procedure-Related Cardiac Troponin-I Release After 
Elective Percutaneous Coronary Intervention: A Single-
Center Randomized Controlled Trial     1017-65·A205
Retrograde Approach in Percutaneous Coronary Intervention 
for Chronic Total Occlusion     1026-138·A258
Routine PCI Improves Short but Not Long-Term Angina Status 
in Patients With An Occluded Infarct Artery: Results 
From the Occluded Artery Trial (OAT)     1024-88·A222
SR123781A, a Synthetic Antithrombin-Dependent Thrombin 
and Factor Xa Inhibitor, in Patients With Non-ST-Segment 
Elevation Acute Coronary Syndromes (NSTEACS): 
Results of an Active-Controlled, Dose-Ranging Study     
806-6·A211
Stroke in Coronary Artery Bypass Grafting (CABG) 
Versus Percutaneous Coronary Intervention (PCI): A 
MetAAnalysis of Randomized Trials     1019-132·A250
Survival and Cardiac Remodeling Benefits In Patients 
Undergoing Late Percutaneous Coronary Intervention 
of the Infarct-Related Artery: Evidence From A 
MetAAnalysis of Randomized Controlled Trials     
1017-50·A201
The Impact of Race and Insurance Status on Utilization 
Rates and Outcomes After Percutaneous Coronary 
Interventions in the Commonwealth of Massachusetts     
1012-127·A242
The Place of Surgical Standby for Coronary Angioplasty     
1026-153·A262
The Porcine Restenosis Model Using Thermal Balloon Injury: 
Comparison With the Model by Coronary Stenting     
1033-150·A267
The Relationship Between ECG Computer Interpretation and 
Catheterization Laboratory Activation Time in Patients 
With Suspected ST-Elevation Myocardial Infarction     
1017-44·A200
Trends in the Use of Drug Eluting Stents     1026-143·A260
Angioscopy
Angioscopic Evaluation of Overlapping Paclitaxel-Eluting 
Stents: Correlation to Histopathologic Observations in 
Swine Coronary Arteries     1014-221·A308
Angiotensin II
A Role for RhoA/Rho-Kinase in Particulate Air Pollution 
Mediated Cardiovascular Changes     1028-198·A341
ACE-Inhibitors May Efficiently Prevent Aortic Dilatation After 
Acute Type A Aortic Dissection     1014-212·A306
Angiotensin Inhibitors Prevent Atrial Fibrillation After 
Cardiothoracic Surgery     1015-91·A15
Antihypertensive Effect of Angiotensin Receptor Blockers 
Versus Other Classes of Antihypertensives in United 
Kingdom Primary Care     1028-178·A336
Enhancement of Collagen Expression by Over-Expression 
of TGFβ1 in Mouse Cardiac Fibroblasts: Involvement 
of LOX-1 Dependent Redox-Sensitive Pathway     
1014-171·A297
Modulating Effects of Intravenous Recombinant Human Brain 
Natriuretic Peptide on Activation of Neuroendocrine 
Systems in Acute Myocardial Infarction Patients With 
Cardiac Dysfunction     1017-78·A208
Molecular Basis of the Stabilization of Angiotensin II Type 1 
Receptor by Valsartan     1028-191·A339
Mutant Atrial Natriuretic Peptide: Enhanced cGMP Activating, 
Natriuretic and Renin-Angiotensin-Aldosterone Inhibiting 
Actions      402-5·A372
Soluble Angiotensin Converting Enzyme 2 Activity Is 
Associated With Worsening Myocardial Function and 
Clinical Outcomes in Patients With Chronic Heart Failure   
807-6·A62
Antiarrhythmia agents
Placebo-Controlled Double-Blind Dose-Ranging Study of 
the Efficacy and Safety of Celivarone for the Prevention 
of Ventricular ArrhythmiATriggered ICD Interventions     
1001-94·A2
Ranolazine Suppresses Ectopic Activity in Isolated Rat Left 
Atrial Appendage     1001-105·A4
Vernakalant Hydrochloride Injection for Recent-Onset Atrial 
Fibrillation: Summary From Two Randomized, Controlled 
Trials and One Open-Label Study     1008-101·A9
Antibodies
Agonizing Over High Circulating Antibody Levels in Preheart 
Transplant Patients     1023-27·A69
Decreased Antibody Responses to Influenza Vaccine in Heart 
Failure Patients     1002-35·A42
Identification of T-Cell Proliferative Response to Cardiac 
Troponin I in Autoantibody-Positive Patients With 
Idiopathic Dilated Cardiomyopathy     1023-8·A64
Anticoagulants
Bridging Oral Anticoagulation With Low Molecular Weight 
Heparin: Experience in 367 Patients With Renal 
Insufficiency     1028-218·A345
Comparison of a Chromogenic Factor X Assay to International 
Normalized Ratio for Monitoring Oral Anticoagulation 
Therapy     1007-175·A282
Economic Evaluation of Bivalirudin With or Without 
Glycoprotein IIB/IIIA Inhibition Versus Heparin With 
Routine Glycoprotein IIB/IIIA Inhibition for Early 
Invasive Management of Acute Coronary Syndromes     
1024-71·A219
Incidence and Bleeding Outcomes of Excess Unfractionated 
Heparin Dosing Among Patients With ST-Segment 
Elevation Myocardial Infarction Undergoing Fibrinolysis     
1017-58·A203
Lack of Impact of Randomized Trials on Percutaneous 
Coronary Intervention (PCI) Practice: Data From the 
American College of Cardiology National Cardiovascular 
Data Registry (ACC-NCDR)     1005-128·A236
Optimal Antithrombotic Therapy in Patients on Hemodialysis 
Requiring Percutaneous Coronary Intervention: 
Bivalirudin Monotherapy or Heparin Plus a Glycoprotein 
IIb/IIIa Inhibitor?     1033-135·A265
Predictors of Excessive Anticoagulation With Unfractionated 
Heparin in STEMI     1017-61·A204
Predictors of Warfarin Discontinuation in Older Patients With 
Atrial Fibrillation     1005-138·A238
Safety of Alternate Day Plavix in Dual Antiplatelet Therapy 
After Drug-Eluting Stent Implantation in Patients on 
Long-Term Anticoagulation     1028-176·A336
SR123781A, a New Synthetic Anticoagulant for the Prevention 
of Venous Thromboembolism in Total Hip Replacement 
Surgery - DRIVE: A Dose Ranging Study      803-4·A310
SR123781A, a Synthetic Antithrombin-Dependent Thrombin 
and Factor Xa Inhibitor, in Patients With Non-ST-Segment 
Elevation Acute Coronary Syndromes (NSTEACS): 
Results of an Active-Controlled, Dose-Ranging Study     
806-6·A211
Suppression of Markers of Thrombin Generation and 
Inflammation in Patients Receiving Low Molecular 
Weight Heparin Compared to Unfractionated Heparin 
for TEE-Guided Cardioversion of Atrial Fibrillation: 
Results From the Assessment of Cardioversion Using 
Transesophageal Echocardiography (ACUTE II) 
Randomized Study     1014-190·A301
Systematic Bayesian MetAAnalysis Evaluating Cardiac 
Outcomes of Low Molecular Weight Heparin Versus 
Unfractionated Heparin Therapy in Patients With ST-
Elevation Acute Myocardial Infarction     1024-49·A214
The Consequences of Major Bleeding in Acute Coronary 
Syndromes     1026-133·A257
The Relative Contribution of Clinical Factors, Treatments, 
Bleeding, and CV Complications to Mortality in 
20,323 Patients Receiving Fibrinolysis for STEMI     
1017-84·A209
Unexpected INR Outcomes and Lab Compliance in Pediatric 
Cardiac Patients Taking Coumadin     1005-141·A239
Warfarin Versus Aspirin for Prevention of Recurrent Stroke 
and Death in Patients With Large Aortic Arch Plaques     
1021-186·A318
Antihypertensive therapy
Antihypertensive Effect of Angiotensin Receptor Blockers 
Versus Other Classes of Antihypertensives in United 
Kingdom Primary Care     1028-178·A336
Assessment Of Angiopoietin 1 and Angiopoietin 2 Gene 
Expression in Peripheral Monocytes After Angiotensin-
Converting Enzyme Inhibition Treatment in Hypertensive 
Patients     1028-181·A337
Comparative Antihypertensive Efficacy of the Oral Direct 
Renin Inhibitor Aliskiren, Irbesartan and Ramipril After a 
Missed Dose: A Double Blind Ambulatory Blood Pressure 
Monitoring Study     817-8·A371
Differential Effect of Baseline Antihypertensive Medications 
on Blood Pressure Changes in Patients With Osteoarthritis 
in the Multinational Etoricoxib and Diclofenac Arthritis 
Long-Term (MEDAL) Study: A Multivariate Analysis     
1036-321·A380
Multiple RAAS Inhibition Influences the Changes of 
Biohumoral Markers in Patients With Heart Failure. Data 
From Aliskiren Observation of Heart Failure Treatment 
(ALOFT) Study     1028-201·A341
Telmisartan Prevents In Vitro the Adverse Effects of Protease 
Inhibitors on Adipocyte Functions     1021-205·A322
Antioxidants
Balance Between Pro-Oxidants and Anti-Oxidants Biomarkers 
in Patients After Percutaneous Coronary Intervention; 
Myeloperoxidase, Oxidized Low Density Lipoprotein, 
and Paraoxonase     1014-189·A301
Dual Therapy With Statins and Antioxidants Are Superior to 
Statins Alone in Decreasing the Cardiovascular Disease 
Risk of Individuals With Diabetes Mellitus and the 
Haptoglobin 2-2 Genotype     1021-226·A328
Endothelial Dysfunction in Human Arterioles Following 
Exposure to Primary Amyloid Light Chain Is Improved by 
MitochondriATargeted Antioxidant     1007-167·A280
High Glucose and Advanced Glycation End Products 
Potentiate IL-17-Mediated Human Coronary Artery 
Smooth Muscle Cell Proliferation, and Is Reversed by 
Resveratrol     1007-182·A283
Inhalation of Hydrogen Gas Protects the Heart From Ischemic 
Reperfusion Injury      406-9·A375
L-Arginine Exerts its Beneficial Effects on Arterial Stifness 
Through the Improvement of Endothelial Function and the 
Reduction of Inflammatory Process in Chronic Smokers     
1021-179·A316
Lipoic Acid Prevents Insulin Resistance and Adipocyte 
Inflammation     1014-158·A294
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Short-Term Treatment With Dextromethorphan Attenuated 
Endothelial Dysfunction, Inflammation, and Oxidative 
Stress in Healthy Male Smokers     1028-175·A335
The Role of Systemic Oxidative Stress in the Regulation of 
Asymmetrical Dimethyl-Arginine (ADMA) Synthesis in 
Homocysteinemia     1014-213·A306
Uncoupling Protein 3 Decreases Oxidant Stress and Protects 
Against Anthracycline Cardiotoxicity     1002-27·A40
Aorta
Acute Type A Dissection: The Surgeon as Risk Factor     
1019-145·A253
Alcohol Consumption and Atherosclerotic Burden in the 
Proximal Thoracic Aorta     1007-161·A279
Aortic Arch Plaques and Risk of Recurrent Ischemic 
Stroke and Death in Medically Treated Stroke Patients     
1021-185·A318
Aortic Stiffness Measured by Pulse Wave Velocity Method 
Predicts Stroke in Patients With Hypertension     
817-6·A371
Central Aortic Stiffness in Patients With Nonischemic Dilated 
Cardiomyopathy     1030-25·A77
Chemokine Upregulation in the Aortic Vasa Vasorum Is 
Associated With Inflammatory Cell infiltration and 
Aneurysmal Dilation of the Aorta     1014-227·A309
Clinical Implications of Aortic Atherosclerosis Evaluated by 
Transesophageal Echocardiography in Surgery of Patients 
With Valvular Heart Diseases     1014-226·A309
Dilation of the Ascending Aorta Is Associated With Clinical 
Risk and CT Features of Atherosclerosis     907-268·A155
Effect of Low Suspicion Presentation of Type A Acute Aortic 
Dissection on Care and Outcomes: Data From the 
International Registry of Acute Aortic Dissection (IRAD)     
1021-159·A312
Extent of Aortic Arch Atheroma Measured by Computed 
Tomography Is Associated With Increased Mortality After 
Open Heart Surgery     907-270·A156
Factors Influencing Arterial Stiffness in HIV Infected Patients     
1035-178·A358
Gender and Race Predict Aortic Size Among Type A 
Aortic Dissection Patients: Observations From the 
International Registry of Acute Aortic Dissection (IRAD)     
815-6·A352
Gender, Clinical, and Diagnostic Contributors to Delayed 
Recognition and Treatment of Acute Aortic Dissection: 
The International Registry of Acute Aortic Dissection 
(IRAD)     1021-165·A313
Iron Content and Heme Metabolism Are Increased in Diabetic 
Atherosclerotic Plaques From Individuals With the Hp 2-2 
Genotype     1014-207·A305
Long-Term Follow-Up After Valve-Sparing Aortic Root 
Remodeling: A Consecutive Series of 55 Yacoub 
Procedures     1020-82·A273
Low Suspicion Presentation of Type B Acute Aortic 
Dissection Leads to Increased Mortality: Data From the 
International Registry of Acute Aortic Dissection (IRAD)     
1021-172·A315
Minimally Invasive Approach for Aortic Valve Replacement in 
The Elderly Is Associated With Lower Mortality: A Case 
Matched Study     1006-81·A271
Real Time Intrathoracic Impedance Is Correlated With Arterial 
Pressure     1030-2·A72
Role of Age in Acute Type A Aortic Dissection Outcome: 
Report From the International Registry of Acute Aortic 
Dissection (IRAD)     1021-168·A314
The Efficacy of Stenting at Aorta in Takayasu Arteritis     
1021-177·A316
Warfarin Versus Aspirin for Prevention of Recurrent Stroke 
and Death in Patients With Large Aortic Arch Plaques     
1021-186·A318
Aortic coarctation
Comparing Balloon Angioplasty, Stenting, and Surgery in the 
Treatment of Aortic Coarctation     801-6·A86
Computational Simulations Demonstrate Altered Biomechanics 
in Postoperative Aortic Coarctation Patients     
1018-121·A90
Incidence of Aneurysm Formation After Dacron Patch 
Aortoplasty Repair for Coarctation of the Aorta: Long-
Term Results in a Single Center     1036-314·A379
LV Long-axis Dysfunction in Adult Patients With 
“Corrected” Aortic Coarctation Is Related to a Later 
Age of Intervention and Increased Aortic Stiffness     
1032-125·A96
Aortic diseases
ACE-Inhibitors May Efficiently Prevent Aortic Dilatation After 
Acute Type A Aortic Dissection     1014-212·A306
Aortic Dilation Is Linked to Systemic Endothelial Dysfunction, 
Increased Aortic Stiffness and Excess Plasma Matrix 
Metalloproteinases in Patients With Nonstenotic Bicuspid 
Aortic Valve      816-8·A277
Distal Aortic Growth in Marfan’s Syndrome: Comparison 
Between Patients With and Without Elective Surgery 
of the Aortic Root Using Magnetic Resonance Imaging     
1021-164·A313
Effect of Low Suspicion Presentation of Type A Acute Aortic 
Dissection on Care and Outcomes: Data From the 
International Registry of Acute Aortic Dissection (IRAD)     
1021-159·A312
Gender and Race Predict Aortic Size Among Type A 
Aortic Dissection Patients: Observations From the 
International Registry of Acute Aortic Dissection (IRAD)     
815-6·A352
Low Suspicion Presentation of Type B Acute Aortic 
Dissection Leads to Increased Mortality: Data From the 
International Registry of Acute Aortic Dissection (IRAD)     
1021-172·A315
Prospective Comparison of the Vascular Imaging Capabilities 
of Intracardiac Echocardiography With Trans-Esophageal 
Echocardiography: The ICE-CHIP study     902-273·A112
Real-Time/Live Three-Dimensional Transthoracic 
Echocardiography Is a Clinically Useful Diagnostic Tool 
for Acute Aortic Dissection     1021-163·A313
Role of Age in Acute Type A Aortic Dissection Outcome: 
Report From the International Registry of Acute Aortic 
Dissection (IRAD)     1021-168·A314
Structural Abnormalities in Thoracic Aortic Aneurysm 
Associated With Bicuspid Aortic Valve Can Be 
Identified Noninvasively by Quantitative Ultrasound     
904-277·A130
The Efficacy of Stenting at Aorta in Takayasu Arteritis     
1021-177·A316
Volumetric Analysis by Noncontrast Computed Tomography 
is Comparable to that of Contrast Enhanced Computed 
Tomography in the Follow-Up of Patients With 
Endovascular Abdominal Aortic Aneurysm Repair     
815-7·A353
Aortic regurgitation
Biventricular Adaptation to Aortic Regurgitation in Mice     
908-264·A165
Impact Of Surgical Closure Of Ventricular Septal Defects 
With Prolapsed Aortic Valve On Aortic Cusp Deformity 
Indices Assessed By Two-Dimensional Echocardiography   
1025-119·A92
Long-Term Follow-Up After Valve-Sparing Aortic Root 
Remodeling: A Consecutive Series of 55 Yacoub 
Procedures     1020-82·A273
Survival Benefit Of Aortic Valve Replacement In Patients With 
Severe Asymptomatic Aortic Regurgitation With Normal 
Left Ventricular Ejection Fraction     1027-81·A274
Survival Benefit With BetABlocker Therapy in a Cohort 
of 623 Patients With Severe Aortic Regurgitation     
1036-319·A380
Aortic valve sclerosis
MCP-1 Blockage Inhibits Lipoprotein Accumulation and 
Valvular Calcification in ApoE-/-Mice      816-3·A276
Risk Factors for Incident Aortic Valve Calcification in the 
Multiethnic Study of Atherosclerosis      816-6·A276
Aortic valve stenosis
Aortic Valve Bypass Surgery for the High-Risk Patient With 
Aortic Stenosis     1027-82·A274
Are There Additional Benefits of Aortic Valve Replacement 
for Severe Aortic Stenosis?; Impact on LV Torsion as 
Assessed by Cardiac MRI Sponsored by the American 
Heart Association     907-281·A158
Atorvastatin Attenuates Bioprosthetic Heart Valve Calcficiation 
in a Rabbit Model via a Stem Cell Mediated Mechanism      
816-7·A277
Bicuspid Aortic Valves Are Associated With Increased 
Inflammation and Neovascularization in Severe Aortic 
Stenosis      816-5·A276
Impact of Global Afterload on Left Ventricular Myocardial 
Contractility in Asymptomatic Aortic Stenosis: A SEAS 
Substudy     1036-320·A380
Mitral Valve Tenting Predicts Persistent Functional Mitral 
Regurgitation After Aortic Valve Replacement in Patients 
With Aortic Valve Stenosis     1034-81·A275
Noninvasive Evaluation of the Aortic Root With Multislice 
Computed Tomography: Implications for Transcatheter 
Aortic Valve Replacement     907-251·A151
Pre-Operative Assessment of Aortic Root Morphology Using 
Multi-Detector Computed Tomography in Patients 
Undergoing Percutaneous Aortic Valve Replacement     
907-254·A152
Three-Dimensional Assessment of the Left Ventricular Outflow 
Tract in Aortic Stenosis     903-251·A115
Utility of Peak Ejection Rate by Three-Dimensional 
Echocardiography Over Ejection Fraction in Severe 
Aortic Stenosis     903-254·A116
Aortocoronary bypass
Accuracy of Dual Source CT Coronary Angiography in 
Patients After Coronary Bypass Surgery: Comparison to 
Invasive Angiography in 78 Patients     906-255·A143
Aspirin Is Insufficient in Inhibition of Platelet Aggregation and 
Thromboxane Formation Early After Coronary Artery 
Bypass Surgery      813-5·A223
Clopidogrel and CABG-Related Bleeding: Not as Important as 
Currently Believed?      813-7·A223
The Place of Surgical Standby for Coronary Angioplasty     
1026-153·A262
Understanding Clinical factors Associated With the Lack 
of Use of Internal Mammary Artery Conduit in 
Patients Undergoing Coronary Artery Bypass Surgery     
1013-82·A272
Apoptosis
Adiponectin Blocks IL-18-Mediated Endothelial Cell Death 
Through Activation of Akt and Suppression of NF-ÎºB-
PTEN Signaling     1014-176·A298
Anakinra, Recombinant Human Interleukin-1 Receptor 
Antagonist, Inhibits Apoptosis in Acute Myocardial 
Infarction     1002-8·A36
Anti-Apoptotic Effects of Erythropoietin in Human Vascular 
Endothelial Cells     1007-188·A284
Caspase-Cleaved Cytokeratin-18: An Early Marker of 
Apoptosis in Cardiomyocytes     1002-11·A37
Constrasting Ex Vivo and In Vitro Effects of Pexelizumab on 
Complement Activation and Cell Apoptosis in Patients 
With ST-Segment Elevation Myocardial Infarction 
Undergoing Primary PCI: A Substudy of the APEX-AMI 
Trial     1017-60·A204
Endothelin-1 Receptor Blockade and Left Ventricular 
Unloading Immediately Prior to Reperfusion Result in 
Equivalent Myocardial Salvage Compared to Reperfusion 
Alone in a Rabbit Myocardial Infarction Model     
1003-49·A180
Fas and Fas-Ligand as Indices of Apoptosis in Patients With 
Impaired Glucose Tolerance Following Acute Myocardial 
Infarction     1014-169·A296
Heat Shock Protein 27 Overexpression Prevents Ox-LDL 
Induced Anoikis by Inhibiting the Expression of 
Inflammatory Cytokines and Tissue-Type Plasminogen 
Activator in Vascular Smooth Muscle Cells     
1028-211·A344
Hydrogen Sulfide (H2S) Preconditions the Myocardium 
Against Myocardial IschemiAReperfusion Injury Via Up-
Regulation of Antiapoptotic Signaling     1010-41·A189
Identification of p17 Fragment of Caspase-3 as a Novel 
Circulating Marker for Acute Heart Failure in Humans     
1009-12·A46
Paracrine Cytoprotective Effects of Inner Chorion-Derived 
Human Mesenchymal Stem Cells     1003-78·A187
Physical Training Reduces the Ability of Serum From Patients 
With Heart Failure to Induce Endothelial Cells Death     
1002-26·A40
Serum From Patients With Mild or Severe Heart Failure 
Induces Apoptosis of Adult Cardiomyocytes     
1002-25·A40
Arrhythmias
“ECG-Edit” Function in Reconstruction of Coronary ECG-
gated 64-Multidetector Row Computed Tomography in 
Arrhythmia     905-269·A138
Atrial Fibrillation Progression in Patients With and Without 
Lone Atrial Fibrillation: A Five-Year Prospective Follow-
Up Study     1008-89·A6
Evidence That Post-Contrast Delayed Enhancement Identified 
by Cardiovascular Magnetic Resonance Imaging 
Is an Arrhythmogenic Substrate in Hypertrophic 
Cardiomyopathy     1016-15·A56
Hospitalization After First Atrial Fibrillation Diagnosis: 
Changing Trends and Relation to Practice Pattern     
1008-109·A11
Imaging of Bachmann’s Bundle and Its Arterial Supply 
by MDCT: Implications for Interatrial Conduction 
Abnormalities and Arrhythmias     905-276·A140
Induction of Remodeling Gene Expression During Ectopic 
Activity in Isolated Rat Left Atrial Appendages     
1001-104·A4
Intraventricular Conduction Delays on a 12-Lead ECG Is 
Associated With Significantly Higher Arrhythmic Events 
Than Bundle Branch Block in Patients With an Implanted 
Cardioverter-Defibrillator     1029-92·A28
Left Ventricular Structural Remodeling Increases Cardiac 
Electrical Stability in Exercised Rat     1001-94A·A2
Long-Term Cardiac Arrhythmias Recorded by Insertable Loop 
Recorders in Patients With Depressed Left Ventricular 
Function After Acute Myocardial Infarction: The 
CARISMA Study     1003-87·A188
Palpitations as an Indication of Heart Disease in Children     
1011-122·A88
Ranolazine Shortens Repolarization and Improves Myocardial 
Relaxation in Patients With Type-3 Long QT Syndrome     
1015-93·A15
Safety Implications of Irrigation Flow Rates Using 2mm 
and 4mm Tip Electrode for Ablation: Can the 2mm Tip 
Safely Create Large Lesions at Lower Power and Flow?     
1008-107·A11
The Effects of Chiral Isolates of Methadone on HERG Current   
1001-90·A1
Arrhythmias, treatment of
A Novel Pacing Paradigm for Cardiac Resynchronization 
Therapy in Desynchronized Acute LV Dysfunction During 
Atrial Fibrillation      802-3·A13
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AV-FREEZE: Prospective Safety Assessment of Cryo-Effects 
on the Human AV Node     1008-90·A7
Chronic Coupled Pacing Reverses Remodeling in Heart Failure 
Dogs With Rapid Atrial Fibrillation     1022-105·A23
Impedance Phase Angle Optimizes Electrode-Tissue Contact 
and Is Superior to Contact Force to Predict RF Lesion 
Formation and Tissue Popping: Improving Safety and 
Efficacy of Ablation Using Open Irrigation Catheters      
811-4·A27
Paracardioscopic Creation of a Comprehensive Biatrial Lesion 
Pattern During Minimally Invasive Atrial Fibrillation 
Treatment     1008-115·A12
Prospective Comparison of the Septal Imaging Capabilities of 
Intracardiac Echocardiography With Trans-Esophageal 
Echocardiography: The ICE-CHIP Study      811-5·A27
Pulmonary Vein Antrum Isolation for the Treatment of Atrial 
Fibrillation in Adults With Congenital Heart Disease     
1025-126·A93
Safety Implications of Irrigation Flow Rates Using 2mm 
and 4mm Tip Electrode for Ablation: Can the 2mm Tip 
Safely Create Large Lesions at Lower Power and Flow?     
1008-107·A11
Should the Maze Procedure Be Utilized for Elimination 
of Atrial Fibrillation in Patients With Hypertrophic 
Cardiomyopathy?     1020-95·A273
Statin Therapy and Exercise Induced Ventricular Arrhythmias     
909-270·A174
The Natural Compound Acacetin Prolongs Atrial Refractory 
Period and Prevents Experimental Atrial Fibrillation in 
Anesthetized Dogs     1001-99·A3
Visualizing Ablation Gaps in Vitro Using a Deflectable Fiber 
Optic Endocardial Visualization Catheter     1008-97·A8
Arterial stiffness
Senescent Vascular Smooth Muscle Cells Play an Important 
Role in the Formation of Vascular Calcification      
406-6·A374
A Randomized Prospective Study to Compare the Effects of 
Three Anti-hypertensives on Plasma Adiponectin and 
Arterial Stiffness     1028-216·A345
Abnormal Arterial-Ventricular Function in Early Chronic 
Kidney Disease: A Pattern Resembling Heart Failure With 
Preserved Ejection Fraction     901-253·A98
Acute Effects of Passive Smoking on Peripheral Vascular 
Function     1007-208·A289
Adipocytokines in the Relationship between Adiposity and 
Arterial Stiffness     1014-192·A302
Aortic Stiffness Measured by Pulse Wave Velocity Method 
Predicts Stroke in Patients With Hypertension     
817-6·A371
Arterial Stiffness and Endothelial Dysfunction as 
Consequences of Hypertension Disease Lead to Impaired 
Microcirculation of the Brain Represented as Cognitive 
Dysfunction     1007-196·A286
Arterial Stiffness Is Increased in Patients With Hepatitis 
C Virus Seropositivity, but Not in Patients With 
Hepatitis B Virus Seropositivity: The Role of Leptin     
1021-175·A316
Brachial Ankle Pulse Wave Velocity Is Associated With 
Walking Distance in Patients Referred for Evaluation of 
Peripheral Arterial Disease     1007-229·A293
Carotid IntimAMedia Thickness Is Associated With an Index 
of Central Arterial Stiffness but Not Peripheral Arterial 
Stiffness in Hypertensive Patients     1021-178·A316
Early Impairment of Myocardial Function and Large Artery 
Remodeling Are Associated With an Enhanced Left 
Ventricular Inotropic Function in Prehypertensive 
Subjects      805-8·A331
Effects of a Long Term Lifestyle and Exercise Intervention on 
Arterial Structure, Function, and Compliance in Healthy 
Patients With Type II Diabetes     1028-226·A347
Essential Hypertensive Subjects With Exaggerated Blood 
Pressure Response During Treadmill Test Are 
Characterized by Accelerated Arterial Stiffening and 
Augmented Asymmetric Dimethylarginine Levels     
1014-182·A299
Evidence for no Global Effect of Metabolic Syndrome, per 
se, on Early Hypertensive Sequelae. Insights from 
the Hippokration Hellenic Hypertension (3H) Study     
1035-158·A353
Evidence to Support the Role of the Aortic Reservoir via 
a Direct Mechanism in Determination of the Pressure 
Waveform With Ageing     1028-189·A339
Gender-Related Difference in Arterial Elastance During 
Exercise in Patients With Diabetes Mellitus     
1014-205·A305
Genetic Polymorphisms Are Associated With the 
Response of Arterial Function to Acute Inflammation     
1007-215·A290
Graded Association Between Carotid Intima Media Thickness, 
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Systemic Levels of the Carbamylation Product Protein Bound 
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Adult Bone Marrow Cells Differentiate Into Multiple 
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1014-199·A303
Cardiac Chimerism Following Intramyocardial Mesenchymal 
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Disease: The Canadian VP and GOALL Registries 
Experience     1005-139·A238
Cholesterol screening
Integrated Coronary CTA in an Office Based Cardiology 
Practice Reduces Myocardial Perfusion Imaging and 
Exercise Treadmill Testing in the Setting of Increased 
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Disease From the DUAAL Study     1031-42·A224
Effect of Chronic Statin Therapy on Hospital Course 
in Patients With Acute Myocardial Infarction     
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in Patients With Atrial Fibrillation and Arterial 
Hypertension     1008-104·A10
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in 64-Slice Computed Tomographic Angiography in 
Comparison to the Conventional Method and Its effect on 
Time Efficiency     906-279·A149
Association of Myocardial Ischemia as Assessed by Stress 
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Left Ventricular Wall Motion - A Multicenter Study 
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of Radiation Using Non-stress Magnetocardiography     
1031-72·A231
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905-251·A134
Left Ventricular Torsion: An Important Mechanism for 
Maintaining Normal Filling Pressures--A Speckle 
Tracking Echocardiography Study in Normal Subjects     
1030-37·A80
Load Dependence of 2D Strain Rate and Doppler Tissue 
Myocardial Velocities: Analysis During ExtrACorporeal 
Life Support     904-275·A130
Localization of Cardiac Resynchronization According to 
Echocardiography: Single Center Pilot Trial Results     
904-271·A129
Longitudinal Changes in Cardiac Parameters and Biomarkers 
Associated With Rapid Half-Marathon Training in 
Previously Sedentary Subjects     1007-200·A287
Longitudinal Strain Delay Index by Speckle Tracking Imaging: 
A New Marker of Response to Cardiac Resynchronization 
Therapy     1022-104·A23
LV Long-axis Dysfunction in Adult Patients With 
“Corrected” Aortic Coarctation Is Related to a Later 
Age of Intervention and Increased Aortic Stiffness     
1032-125·A96
Measurement of Temporal Heterogeneity as a Marker of 
Ischemia at Exercise Stress Echocardiography: Use 
of Contraction Front Mapping of Real-Time Three-
Dimensional Echo      804-5·A133
Monitoring Apical Twist Alone as Compared to Torsion Is 
Adequate for Evaluating Heart Function     904-259·A126
Multiple Segmental Left Ventricular Asynergy in Patients With 
Cardiac Sarcoidosis With Septal Thinning: Quantitative 
Assessment by Speckle-Tracking Echocardiography     
1023-1·A63
Myocardial Doppler Imaging Can Detect Subclinical Cardiac 
Dysfunction After Anthracycline-Based Chemotherapy     
902-257·A108
Myocardial Fibrosis Severity and Location Predict Diastolic 
Dysfunction     907-279·A157
Myocardial Systolic Function in the Region of Left Ventricular 
Pacing Lead Predicts the Acute Response to Cardiac 
Resynchronization Therapy in Patients With Heart 
Failure Assessed by Two-Dimensional Speckle Tracking 
Echocardiography     1030-14·A75
Myocardial Velocity Abnormalities Precede Shortening 
Abnormalities in Hypertensive Heart Disease: A Speckle 
Tracking Study     904-260·A126
Noninvasive Diagnosis of Acute Coronary Syndrome Among 
Patients With Chest Pain by Echocardiographic Detection 
of Postischemic Regional Left Ventricular Diastolic 
Dyssynchrony Using Strain Image Derived From 2D 
Speckle Tracking     901-280·A104
Noninvasive Estimation of Left Ventricular Filling Pressure 
by E/e’ Is a Powerful Predictor of Major Adverse Cardiac 
and Cerebrovascular Events in Patients With A First ST 
Elevation Acute Myocardial Infarction     1014-160·A295
Obesity Is the Major Predictor for Development of Left 
Ventricular Remodeling in Young Adults: Bogalusa Heart 
Study     901-274·A103
Phosphodiesterase-5 Inhibitors Reduce Myocardial Infarction, 
Apoptosis and Improve Post-Ischemic Ventricular 
Function in Female Mice     1003-43·A178
Poor Reproducibility of Echocardiographic Measures of 
Mechanical Dyssynchrony in Cardiac Resynchronization 
Therapy (CRT)      804-8·A133
Preclinical Myocardial Dysfunction Is Detected by Strain/
Strain Rate Before Conventional Measures in Patients 
Undergoing Adjuvant Breast Cancer Treatment With 
Trastuzumab (Herceptin™)     905-250·A134
Prediction of Cardiac Resynchronization Therapy Response by 
Tri-Plane Echocardiographic Measures of Dyssynchrony     
1030-20·A76
Predictive Power of Preoperative Non-Stress 
Echocardiographic Evaluation for Postoperative 
Cardiovascular Events in Noncardiac Surgery     
901-254·A99
Predictors for Improvement of Exercise Capacity After Mitral 
Valve Surgery in Patients With Chronic Severe Mitral 
Regurgitation     901-284·A105
Predictors of Left Ventricular Systolic and Diastolic 
Dyssynchrony After Non-ST Elevation Myocardial 
Infarction     902-255·A107
Prevalence of Free Floating Thrombi in the Right 
Heart Complicating Acute Pulmonary Embolism     
1021-193·A320
Prevalence of Left Ventricular Systolic Dyssynchrony in Heart 
Failure Patients With Narrow QRS Complexes Assessed 
by Real-time Three-dimensional Echocardiography     
903-263·A118
Prospective Evaluation of the Clinical Application of the 
ACCF/ASE Appropriateness Criteria for Transthoracic 
Echocardiography      818-5·A269
Quantification of Mechanical Dyssynchrony: Comparison 
Between 2-Dimensional Speckle Tracking and Doppler 
Tissue Imaging Derivations     901-262·A100
Radial and Longitudinal Dyssynchrony in Narrow QRS Heart 
Failure     906-285·A150
Range of Normality of Echocardiographic Measures 
of Mechanical Synchrony in Healthy Individuals: 
Implication for a Multiparametric Approach in CRT 
Patients     905-259·A136
Ranolazine Shortens Repolarization and Improves Myocardial 
Relaxation in Patients With Type-3 Long QT Syndrome     
1015-93·A15
Real-Time 3-Dimensional Echocardiographic Quantification 
of Left Ventricular Volumes: Multicenter Study for 
Validation With Magnetic Resonance Imaging and 
Investigation of Sources of Error     902-270·A111
Real-Time Three-Dimensional Echocardiography Provides 
New Insight Into the Mechanisms of Tricuspid Valve 
Regurgitation in the Patient With Hypoplastic Left Heart 
Syndrome     1011-120·A87
Real-Time/Live Three-Dimensional Transthoracic 
Echocardiography Is a Clinically Useful Diagnostic Tool 
for Acute Aortic Dissection     1021-163·A313
Reduction in Left Ventricular Systolic Longitudinal Function 
Precedes Global Impairment of Systolic Function in 
Patients With Marfan Syndrome     901-283·A105
Regional Location of Left Ventricular Dyssynchrony Is 
Associated With Extent of Reverse Remodeling     
901-260·A100
Relation Between Global Left Ventricular Longitudinal Strain 
Assessed by Automated Function Imaging and Left 
Ventricular Ejection Fraction     902-252·A106
Restrictive Diastolic Filling Pattern Is a Predictor of Outcome 
in Patients Presenting With and Without Heart Failure 
After Acute Myocardial Infarction. Results From an 
Individual Patient MetAAnalysis (MeRGE-AMI)     
907-285·A159
Right Ventricular Dysfunction in Transient Stress 
Cardiomyopathy: Prevalence and Clinical Characteristics     
1016-10·A55
Right Ventricular Volumes From Modified Subcostal Views 
Obtained With 4-Dimensional Echo in Adult Patients 
are More Accurate Than Those From Apex Views     
902-272·A111
Role of the Left Atrial Function on the Pseudonormalization 
of the Transmitral Flow Velocity Pattern Evaluated by 
Newly Developed Automatic Left Atrial Volume Tracking 
Technique     904-265·A127
Sensitivity and Predictive Value of Transthoracic 
Echocardiographic Findings in Patients With Suspected 
Endocarditis     901-251·A98
Short Axis Rotation and Circumferential Strain in Patients 
With Single Ventricle     1025-123·A93
Strain Rate Imaging Demonstrates Long-Term Functional 
Improvement of Left Atrial and Left Ventricular Nonseptal 
Regions After Alcohol Septal Ablation in Obstructive 
Hypertrophic Cardiomyopathy     904-262·A127
The 17-Segment Regional Wall Motion Scoring Index May be 
Superior to Simpson’s Rule for the Calculation of Left 
Ventricular Ejection Fraction     902-263·A109
The Apolipoprotein AI Mimetic Peptide L-4F Improves 
Cardiac Performance in Septic Rodents     1002-39·A43
The Effect of Biventricular Pacing Optimization on Left 
Ventricular Torsion as Evaluated by Speckle Tracking 
Imaging     904-272·A129
The Effect of Intramyocardial Bone Marrow Cell Injection 
on Left Ventricular Dyssynchrony and Global Strain     
901-261·A100
The Effects of Valsartan and Spironolactone on Collagen 
Metabolism and Heart Function in Patients After Acute 
Myocardial Infarction With Aneurysm     1028-164·A333
The Impact of Endurance Training on Left Ventricular Strain: 
Enhanced Systolic Function and a Novel Example of 
Ventricular Interdependence     901-273·A103
The Impact of N Terminal Pronatriuretic Peptide (NT 
Pro BNP) on Number Needed to Screen (NNS) 
by Echocardiography for Systolic Dysfunction     
1002-28·A40
The Prevalence of Asymptomatic Left Ventricular Dysfunction 
in Subjects at Risk of Heart Failure. Results of the 
PROBE-HF Study     1009-34·A51
The Role of NT-proBNP and Echocardiography for Screening 
Asymptomatic Left Ventricular Dysfunction in Subjects 
at Risk of Heart Failure. Results of the PROBE-HF Study   
1009-35·A51
The Use of Myocardial Deformation Imaging Based on 
Ultrasonic Pixel Tracking to Identify Reversible 
Myocardial Dysfunction     901-285·A106
Three-Dimensional Assessment of the Left Ventricular Outflow 
Tract in Aortic Stenosis     903-251·A115
Tissue Doppler Assessment of Left Ventricular Filling Pressure 
for the Prediction of First Cardiovascular Events in 
Elderly: A Prospective Study      804-4·A133
Tissue Doppler-Derived Ventricular Stiffness Index Can 
Predict the Long-Term Survival in Patients With 
Restrictive Cardiomyopathy     1023-2·A63
Transmitral Vortex Formation: A Reliable Indicator for 
Pseudonormal Diastolic Dysfunction     901-279·A104
Transmural Myocardial Strain Profile is A Useful Method 
to Estimate the Regional Myocardial Damage after 
Reperfused ST Elevation Acute Myocardial Infarction 
: A Comparison with Tc-99m Sestamibi Single Photon 
Emission Computed Tomography     1028-173·A335
Two-Dimensional Echocardiographic Peak Systolic Strain Rate 
Inversely Correlates with LV Mass and Is Depressed in 
Patients With Diastolic Heart Failure     902-254·A107
Two-Dimensional Strain (2D-Strain): Evaluation of Systolic 
Longitudinal and Radial Strain in a Large Cohort of 
Normal Probands     902-251·A106
Two-Dimensional Strain in the Evaluation of Early Alterations 
of Global and Regional Left Ventricular Function in 
Prehypertension     904-280·A131
Underestimation of the Prevalence of Multiple Lesions 
in Patients With Papillary Fibroelastoma: An 
Echocardiographic and Surgical Prospective Study     
902-268·A110
Use of Hand-Carried Ultrasound, Clinical Assessment, and 
BNP to Estimate Abnormal Left Ventricular Filling 
Pressures in Inpatients Referred for Right Heart 
Catheterization     901-275·A103
Utility of Peak Ejection Rate by Three-Dimensional 
Echocardiography for Risk Stratification Post-Myocardial 
Infarction     902-283·A114
Utility of Peak Ejection Rate by Three-Dimensional 
Echocardiography Over Ejection Fraction in Severe 
Aortic Stenosis     903-254·A116
Validation of a Multiparametric Strategy As a Comprehensive 
Approach to Optimize Echocardiographic Selection of 
Patients for CRT     1023-34·A70
Value of Real-Time Three-Dimensional Echocardiography in 
Patients With Hypertrophic Cardiomyopathy. Comparison 
With Two-Dimensional Echocardiography and Magnetic 
Resonance Imaging     902-284·A115
Velocity Vector Imaging in Pediatric Hypertrophic 
Cardiomyopathy     904-261·A127
Waist Circumference, Body Mass Index, & Cardiac Parameters 
in Children & Adolescents     1011-119·A87
Ejection fraction
Analysis of a New Automated Ejection Fraction Method 
in 64-Slice Computed Tomographic Angiography in 
Comparison to the Conventional Method and Its effect on 
Time Efficiency     906-279·A149
Differences in Left Ventricular Ejection Fraction Assessment 
Between Transthoracic Echocardiography and Cardiac 
Gated Rubidium Positron Emission Tomography     
909-261·A172
Effect of Degree of Left Ventricular Systolic Dysfunction on 
Systolic Versus Diastolic Asynchrony in Heart Failure 
Patients     1030-35·A79
Effect of Enhanced External Counterpulsation on Ejection 
Fraction in Patients With Ischemic Heart Disease     
1031-70·A231
Effects of Infarct Size on Left Ventricular Contractility and 
Preload: A Model Study     1023-15·A66
Follow-Up Left Ventricular Ejection Fraction in the DEFINITE 
Trial Population Predicts Outcome Regardless of 
Cardioverter-Defibrillator Status     1015-111·A19
Is Hyperdynamic Left Ventricular Ejection Fraction a Poor 
Prognostic Factor?     908-285·A169
Is There a Difference in 3-Dimensional Derived Ejection 
Fraction Between the Sexes: A CV MRI Study in 2,500 
Patients     1030-6·A73
Left Ventricular Shape Analysis by a new Real-Time 
Three Dimensional Echocardiography Based Index of 
Geometrical Sphericity     903-256·A117
Low Dose Metformin Therapy Improves Cardiac Function in a 
Murine Model of Heart Failure     1002-33·A41
No Difference in ICD Treated Ventricular Arrhythmias in 
Patients With Left Ventricular Ejection Fraction of 31-35 
% Compared to ≤ 30 %     1022-115·A26
Plasmapheresis: A Potential Immunomodulatory Therapy 
for Patients With Nonischemic Cardiomyopathy     
1030-19·A76
Relation Between Global Left Ventricular Longitudinal Strain 
Assessed by Automated Function Imaging and Left 
Ventricular Ejection Fraction     902-252·A106
Relation of Angiographic Patterns and Ejection Fraction 
to Clinical Outcomes in the COURAGE Trial     
1012-133·A244
The 17-Segment Regional Wall Motion Scoring Index May be 
Superior to Simpson’s Rule for the Calculation of Left 
Ventricular Ejection Fraction     902-263·A109
The Combination of BetA1 Arginine389 and 
AlphA2cDeletion322-325 Adrenergic Receptor 
Polymorphisms Demonstrate the Greatest Improvement 
in Left Ventricular Ejection Fraction on BetABlockade 
Therapy in the African American Heart Failure Population 
1009-18·A47
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Women Face Higher Risk for Decline in Left Ventricular 
Ejection Fraction Following Orthotopic Liver Transplant     
1035-168·A356
Electrocardiography
A Comparison Study of Reproducibility of Quantitative and 
Qualitative Echo-Derived Indices of Dyssynchrony     
901-259·A99
Acute Sleep Deprivation Is Associated With Prolonged 
Electrocardiographic P-Wave and QT Dispersion in 
Healthy Young Adults     1029-99·A30
All-Cause and Cardiovascular Mortality in Relation to 
Changing Heart Rate During Treatment of Hypertension: 
The LIFE Study     1028-193·A339
Comparison of Endomyocardial and Epimyocardial Radial 
Strain Between Hypertensive Patients With and Without 
Electrocardiographic Strain Pattern     809-4·A349
Disparities in the Initial Assessment of Acute Chest Pain in the 
Emergency Department     1012-141·A246
Does Statin Pre-treatment Promote Thrombolysis in Patients 
With Acute Myocardial Infarction Treated With 
Thrombolytic Therapy?     1017-62·A204
ECG and Echocardiographic Abnormalities in Traumatic Brain 
Injury     1023-17·A67
Electrocardiographic Abnormalities Are Common Among 
Preparticipation ECGs in a Population of Elite US College 
Athletes     1029-110·A32
Enhanced Detection of Coronary Artery Disease and 
Myocardial Ischaemia Using Spectral Analysis of Energy-
based ECG Indices     1029-116·A34
Feasibility of ECG-Gated CT-Fluoroscopy Registration in 
Catheter-Based Atrial Fibrillation Ablation     1008-99·A8
Fragmentation of Wide QRS on 12-Lead ECG Predicts 
Myocardial Scar     1029-108·A32
Fragmented QRS Complexes on 12-Lead ECG Predict 
Significant Mortality in Patients With Congestive Heart 
Failure     1029-112·A33
Fragmented QRS Complexes on a 12-lead ECG Is a Marker 
of Greater Myocardial Scaring Related to Coronary 
Artery Disease by Magnetic Resonance Imaging     
1029-107·A32
Fragmented QRS: A Novel Marker to Identify Disease in 
Patients Suspected of Having Arrhythmogenic Right 
Ventricular Cardiomyopathy     1029-105·A31
Functional Recovery After Acute Myocardial Infarction: A 
Comparison Between Angiography, Electrocardiography 
and Cardiovascular Magnetic Resonance Measures of 
Microvascular Injury     907-276·A157
Greater Regression of Electrocardiographic Left Ventricular 
Hypertrophy During Hydrochlorothiazide Therapy in 
Hypertensive Patients and the Interaction With Losartan 
Versus Atenolol Therapy: The LIFE Study      805-3·A329
Heart Failure Patients With Preserved Ejection Fraction Have 
a Complex Relationship Between Systolic Mechanical 
Dyssynchrony and QRS Width - Findings From the 
Dyssynchrony Induced by Ventricular Exertion in Heart 
Failure (DIVE-HF) Study     1030-30·A78
High Throughput Screening of Drug-Induced QT Prolongation 
in Small Animals by Micro-Magnetocardiography System 
With Superconducting Quantum Interference Device: 
Comparison With Electrocardiography     1029-101·A30
How Useful Is the 12-Lead ECG for Detection and 
Localization of Atrial Septal Defects? A Study in 326 
Adolescent and Adult Patients     1025-125·A93
Impact of the Absence of Significant Changes on the 
Electrocardiogram Throughout the Hospital Phase in 
Patients With Non ST Segment Elevation Myocardial 
Infarction: Data From the RICO Survey     1017-71·A206
Intraventricular Conduction Delays on a 12-Lead ECG Is 
Associated With Significantly Higher Arrhythmic Events 
Than Bundle Branch Block in Patients With an Implanted 
Cardioverter-Defibrillator     1029-92·A28
Is J-Point Elevation a Specific Electrocardiographic Marker of 
Idiopathic Ventricular Fibrillation?     1015-104·A17
Prehospital Electrocardiograms: Potential Answer to the Time-
to-Reperfusion Challenge     1017-86·A209
Quantitative ECG Analysis Improves Management of Atrial 
Tachyarrhythmias Compared to Experts      405-6·A373
Regional Myocardial Temperature During Coronary Occlusion 
in the Swine: Comparison With Electrocardiographic 
Changes     1003-73·A185
Short-Term Prognostic Implications of Electrocardiographic 
Versus Echocardiographic Left Ventricular Hypertrophy in 
Patients With a First Non-ST-Elevation Acute Myocardial 
Infarction     1010-70·A195
ST-Segment Deviation Resolution Is an Indicator for Coronary 
Artery Patency Prior to Primary Percutaneous Coronary 
Intervention in Patients With Acute Myocardial Infarction   
1017-41·A199
Susceptibility to Ventricular Fibrillation Produced by Chest 
Blows (Commotio Cordis) Is Related to the Length of the 
QT Interval     1015-101·A17
The “PhysioGlove”®, a New Diagnostic 12-Lead ECG 
Acquisition Device: Assessment of Reproducibility and 
Diagnostic Accuracy Compared to ECGs Acquired Using 
the Conventional ECG Cable     1029-103·A31
The Prognostic Significance of Left Axis Deviation in Patients 
With Left Bundle Branch Block     1029-102·A30
The Prognostic Significance of QT Interval Prolongation in a 
Clinical Population of Male Veterans     1029-98·A30
The Relationship Between ECG Computer Interpretation and 
Catheterization Laboratory Activation Time in Patients 
With Suspected ST-Elevation Myocardial Infarction     
1017-44·A200
Electron beam CT
Characteristics of Persons Who Have Cardiovascular Events 
With Absent or Minimal Coronary Calcification: 
The Multiethnic Study of Atherosclerosis (MESA)      
812-3·A160
Increased Coronary Artery Calcium Scores on Electron Beam 
Computed Tomography is Associated With Increased 
Utilization of Aspirin Therapy     907-256·A152
Low Density Lipoprotein, High Density Lipoprotein and 
Lipoprotein (a) Subclasses and Their Relationship 
With Coronary Artery Calcification Is Asymptomatic 
Population     906-283·A150
Low Incidence of Hemodynamically Significant Coronary 
Artery Disease in Subjects With Increased Coronary 
Artery Calcium     905-270·A138
Risk Factors for Incident Aortic Valve Calcification in the 
Multiethnic Study of Atherosclerosis      816-6·A276
Electropharmacology
Ranolazine Suppresses Ectopic Activity in Isolated Rat Left 
Atrial Appendage     1001-105·A4
The Natural Compound Acacetin Prolongs Atrial Refractory 
Period and Prevents Experimental Atrial Fibrillation in 
Anesthetized Dogs     1001-99·A3
Electrophysiology
Accurate Detection of Coronary Artery Disease Without Use 
of Radiation Using Non-stress Magnetocardiography     
1031-72·A231
Comparison of Microvolt T-Wave Alternans With Invasive and 
Noninvasive Risk Stratifiers for Sudden Cardiac Death in 
Hypertrophic Cardiomyopathy     1029-106·A31
Deficiency of Inositol 1,4,5-Triphosphate Receptor Type 1 
in the Murine Heart Causes HV Prolongation Without 
Alteration in Cardiac Structure or Function     1001-98·A2
Effects of Verapamil Suggest that Calcium Current Is 
Important in Maintaining Ventricular Fibrillation Lasting 
More Than Three to Four Minutes     1001-89·A1
Feasibilty of Transesophageal Electrophysiologic Study in a 
Child Six to Ten Years Old for Wolff-Parkinson-White 
Syndrome in Out-Patient Clinic     1004-126·A85
Fragmentation of Wide QRS on 12-Lead ECG Predicts 
Myocardial Scar     1029-108·A32
High-Density Mapping of Atrial Fibrillation in Humans: 
Relationship Between High Frequency Activation and 
Electrogram Fractionation     1001-115·A6
INO-8875, a Highly-Selective A1 Adenosine Receptor 
Agonist: Evaluation of Chronotropic, Dromotropic and 
Hemodynamic Effects in Rats     1001-101·A3
Limited Relevance of Invasive Electrophysiologic Testing 
in Patients Meeting Current Primary Prevention 
Indications for an Implantable Cardioverter-Defibrillator     
1022-114·A26
Magnetic Catheter Ablation of Right Atrial Flutter--The 
Importance of an 8 mm Tip Electrode to Achieve 
Bidirectional Block     1008-114·A12
Molecular Basis of the Inhibition of Cardiac IK1 Current by 
Protein Kinase C: Role of PKC Beta and Kir2.x Channel 
Subunit Heterogeneity     1001-92·A1
No Documented Tachycardia in Children Without 
Preexcitation Syndrome; Results of Transesophageal 
Electrophysiological Study     1011-121·A88
The “Single-Big-Cryo-Balloon” Technique for Pulmonary Vein 
Isolation in Paroxysmal Atrial Fibrillation     1015-90·A14
The Prognostic Significance of Left Axis Deviation in Patients 
With Left Bundle Branch Block     1029-102·A30
Transmural Propagation of Wavefronts During Long Duration 
Ventricular Fibrillation     1001-103·A3
Emergency care
Bioelectrical Impedance Analysis (BIA) in Differentiating 
Acute Dyspnoea Due to Decompensated Heart Failure in 
Emergency Department     1033-155·A268
Disparities in the Initial Assessment of Acute Chest Pain in the 
Emergency Department     1012-141·A246
Nine Independent Regional ST-Elevation Myocardial 
Infarction Networks Exceed D2B Alliance Benchmark     
1036-315·A379
Prehospital Wireless Transmission of STEMI 
Electrocardiograms to a Cardiologist Reduces Door-
to-PCI Times to Less Than One-Half of the ACC/AHA 
Guidelines     1010-85·A198
Real-Time/Live Three-Dimensional Transthoracic 
Echocardiography Is a Clinically Useful Diagnostic Tool 
for Acute Aortic Dissection     1021-163·A313
The Relationship Between ECG Computer Interpretation and 
Catheterization Laboratory Activation Time in Patients 
With Suspected ST-Elevation Myocardial Infarction     
1017-44·A200
Utility of Multi-Detector Computed Tomography (MDCT) as a 
Diagnostic Triage Tool for Patients Presenting With Chest 
Pain to the Emergency Department: A MetAAnalysis     
906-256·A144
Endocarditis
Characteristics of Children Hospitalized With Infective 
Endocarditis     1018-119·A89
Sensitivity and Predictive Value of Transthoracic 
Echocardiographic Findings in Patients With Suspected 
Endocarditis     901-251·A98
The Changing Epidemiology of Pediatric Infective 
Endocarditis: A Comparison Across 74 Years at a Single 
Children’s Hospital     801-3·A85
Endothelial function
A Highly Purified OmegA3 Fatty Acid Derivative Improves 
Endothelial Function in Patients With Stable Coronary 
Artery Disease     1007-191·A285
Acute Effects of Passive Smoking on Peripheral Vascular 
Function     1007-208·A289
Angina, Open Arteries and Endothelial Dysfunction in Women 
With Suspected Ischemia     1021-189·A319
Anti-Apoptotic Effects of Erythropoietin in Human Vascular 
Endothelial Cells     1007-188·A284
Arterial Stiffness and Endothelial Dysfunction as 
Consequences of Hypertension Disease Lead to Impaired 
Microcirculation of the Brain Represented as Cognitive 
Dysfunction     1007-196·A286
Atorvastatin Therapy in Compensated Heart Failure: Effects on 
Oxidative Stress, Remodelling, and Endothelial Function     
1009-37·A52
Cardiac Magnetic Resonance Imaging and Coronary Reactivity 
Testing: A Useful Noninvasive Tool     1031-71·A231
CD4+ CD28null Lymphocytes and Accelerated Atherosclerosis 
in Patients With Systemic Lupus Erythematosus     
1014-178·A298
Chronic Smoking-Yielded Electronegative LDL Induces MEK/
ERK-Mediated Metalloproteinase Activation in Human 
Endothelial Progenitor Cells     1007-160·A278
Circulating Endothelial Cells and Circulating Progenitor 
Cells in Hypertension in Pregnancy: A Balance Between 
Endothelial Damage and Repair?     1007-217·A291
Circulating Endothelial Cells and Plasma von Willebrand 
Factor in Hypertension in Pregnancy: Evidence for 
Endothelial Damage/Dysfunction     1028-196·A340
Circulating Progenitor Cells and Endothelial Dysfunction in 
Patients With Coronary Heart Disease and Concomitant 
Abnormal Glucose Metabolism     1007-209·A289
CYP4A Polymorphism but No Other Vasomotor or 
Inflammatory Genes Correlates With Coronary 
Endothelial Function in Patients With Coronary Artery 
Disease: The ENCORE Trials     1014-193·A302
Digital Thermal Reactivity Decreases With the Severity of 
Coronary Artery Disease Diagnosed by 64 Multidetectors 
CT     906-281·A149
Does a Sirolimus-Eluting Stent Affect Endothelial Function?--
Comparison With Bare Metal Stent     1014-219·A307
Effect of Coronary Endothelial Dysfunction on Left Ventricular 
Function in Patients With Never-Treated Hypertension     
809-7·A350
Effect of Selective Serotonin Reuptake Inhibitors (SSRI) on 
TNFAInduced Expression of Cell Adhesion Molecules in 
Endothelial Cells     1028-183·A337
Endothelial Dysfunction in Human Arterioles Following 
Exposure to Primary Amyloid Light Chain Is Improved by 
MitochondriATargeted Antioxidant     1007-167·A280
Endothelial Serum Markers, Serum Uric Acid and 
Lipoprotein (a), Correlate With Activity of Vasospasm     
1014-191·A301
Erythropoietin Stimulates Normal Endothelial Progenitor 
Cell-Mediated Endothelial Turnover, but Attributes 
to Neovascularization Only in the Presence of Local 
Ischemia     1007-224·A292
HDL-Cholesterol as a Predictor of the Flow-Mediated 
Dilatation of the Coronary Artery in Postmenopausal 
Women     1007-194·A286
Impaired Glucose Tolerance Is Associated With Endothelial 
Damage Following Acute Myocardial Infarction     
1003-66·A184
Inhibition of Interleukin-1 Activity by Anakinra Improves 
Endothelial Function and Coronary Flow Reserve 
Through Inhibition of Nitro-Oxidative Stress and 
Endothelin Release     903-268·A120
Lifestyle Physical Activity Improves Arterial Compliance 
in Mildly Hypertensive, Sedentary, African-American 
Women     1035-179·A358
MCP-1 Blockage Inhibits Lipoprotein Accumulation and 
Valvular Calcification in ApoE-/-Mice      816-3·A276
One-Year Clinical Follow-Up of Endothelial Progenitor 
Cell Capture Stent Versus Uncoated Stent in Patients 
Undergoing Primary Percutaneous Coronary Intervention 
for Acute Myocardial Infarction     1033-144·A266
Pulse Pressure Is a Predictor of Vascular Endothelial Function 
in Healthy Volunteers      805-6·A330
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Relationships Between Vascular/Plasma Biopterins and 
Endothelial Nitric Oxide Synthase Coupling, Endothelial 
Function, and Inflammation in Human Atherosclerosis     
1014-181·A299
Short-Term Exercise Training Without Specific Diet Improves 
Endothelial Function and HDL Functional Characteristics 
in Patients With Metabolic Syndrome     909-275·A175
Short-Term Treatment With Dextromethorphan Attenuated 
Endothelial Dysfunction, Inflammation, and Oxidative 
Stress in Healthy Male Smokers     1028-175·A335
Simvastatin Improves Flow-Mediated Dilation, but 
Reduces Adiponectin Levels and Insulin Sensitivity in 
Hypercholesterolemic Patients Independent of Doses     
1007-172·A281
The Contribution of Endothelium-Derived Hyperpolarizing 
Factor and Nitric Oxide to Exercise-induced Vasodilation     
1007-165·A279
The Effect of Immune Modulation Therapy on Endothelial 
Function in Patients With Severe Chronic Heart Failure: 
Data From the Advanced Chronic Heart Failure Clinical 
Assessment of Immune Modulation Therapy (ACCLAIM) 
Trial     1009-9·A45
The Effect of Individual Apolipoproteins on Endothelial 
Function and Thrombosis/Fibrinolysis System in Healthy 
Young Individuals     1035-219·A367
Vascular Endothelial Function Predicts Mortality Risk in 
Patients With Advanced Ischemic Chronic Heart Failure     
1007-170·A281
Vascular Function, Endothelial Precursors Cells and 
Angiogenic Factors in Morbid Obesity     1007-203·A288
Endothelin
Atrasentan, an Endothelin: A Receptors Antagonist, Is a Potent 
Antihypertensive Drug With Renoprotective Properties 
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Pulse Pressure Is a Predictor of Vascular Endothelial Function 
in Healthy Volunteers      805-6·A330
Regression of Electrocardiographic Left Ventricular 
Hypertrophy During Antihypertensive Therapy Is 
Associated With Decreased Incidence of New-Onset 
Microalbuminuria: The LIFE Study     1028-194·A340
Short-Term Aspirin Treatment Decreases Wave Reflections in 
Never Treated Hypertensive Patients     1035-224·A368
Significant Increases in Plasma Levels of Oxidized Low 
Density Lipoprotein and Myeloperoxidase After a Single 
Session of Hemodialysis in Patients With Diabetes 
Mellitus Nephropathy     1007-169·A280
Small Artery Elasticity Predicts Development of Hypertension 
in Prehypertensive Patients: Results From a TROPHY 
Substudy     817-4·A370
The Ala379Val Polymorphism of Lipoprotein-Associated 
Phospholipase A2 Affects the Risk for Arterial 
Hypertension and Modifies Platelets Activation     
1031-59·A228
The Prevalence of Asymptomatic Left Ventricular Dysfunction 
in Subjects at Risk of Heart Failure. Results of the 
PROBE-HF Study     1009-34·A51
Three Dimensional and Biatrial Mapping of Atrial 
Tachyarrhythmias in Coronary and Hypertensive Heart 
Disease: Identifying Mechanisms That Initiate and 
Maintain Persistent Atrial Fibrillation     1001-111·A5
Two-Dimensional Strain in the Evaluation of Early Alterations 
of Global and Regional Left Ventricular Function in 
Prehypertension     904-280·A131
Usefulness of the Electronic Activity Monitor During 24-Hour 
Ambulatory Blood Pressure Monitoring in Hypertensive 
Patients at Real World Practices     1028-195·A340
Visceral Fat Related Adverse Effects on Arterial Elastic 
Properties Beyond Body Mass Index Levels: Insights 
From the Hippokration Hellenic Hypertension Study (3H 
Study)     1014-185·A300
Hypertrophy
All-Cause and Cardiovascular Mortality in Relation to 
Changing Heart Rate During Treatment of Hypertension: 
The LIFE Study     1028-193·A339
Association Between Obesity and Left Ventricular Hypertrophy 
1035-170·A356
Cardiotrophin-I Plasma Levels Are Increased in Hypertensive 
Patients With Cardiac Hypertrophy and Diastolic 
Dysfunction      805-5·A330
Cardiovascular Phenotype Predicting Incident Heart Failure in 
Diabetes: The Strong Heart Study     1035-184·A359
Comparison of Endomyocardial and Epimyocardial Radial 
Strain Between Hypertensive Patients With and Without 
Electrocardiographic Strain Pattern     809-4·A349
Delayed Left Ventricular Untwisting Motion Detects 
Early Abnormality in Patients With Hypertension     
904-273·A130
Disparate Effects of Obesity and Left Ventricular Geometry 
on Mortality in 8,088 Elderly With Preserved Systolic 
Function     902-253·A107
Dynamic Left Ventricular Remodeling in vivo in Response 
to Pressure Overload Is Independent of AMPK-alpha2 
Activation     1009-3·A44
Fibulin-2 Regulates Transforming Growth Factor (TGF)-β 
Activation in the Development of Angiotensin-II-Induced 
Myocardial Hypertrophy     1002-7·A36
Fixed Dose Isosorbide Dinitrate/Hydralazine Lowers Blood 
Pressure But Does Not Improve Cardiac Remodeling In 
Diastolic Heart Failure     1002-12·A37
Genome-Wide Linkage Analysis of Electrocardiographic 
and Echocardiographic Left Ventricular Hypertrophy in 
Families With Hypertension     809-3·A349
Greater Regression of Electrocardiographic Left Ventricular 
Hypertrophy During Hydrochlorothiazide Therapy in 
Hypertensive Patients and the Interaction With Losartan 
Versus Atenolol Therapy: The LIFE Study      805-3·A329
Integrin Stimulation Induced Hypertrophy in Neonatal Rat 
Cardiomyocytes Is Nitric Oxide-dependent     1002-6·A36
Left Ventricular Hypertrophy Is Associated With a State 
of Pronounced Inflammatory Activation and Arterial 
Stiffening in Essential Hypertension: A Novel Approach 
to Target Organ Damage     1028-229·A348
N -Terminal Pro B-Type Natriuretic Peptide Predicts 
Mortality in Patients With Left Ventricular Hypertrophy     
809-5·A349
Novel Basis of Interstitial Remodeling in Left Ventricular 
Hypertrophy and Sudden Cardiac Death     1001-102·A3
Regression of Electrocardiographic Left Ventricular 
Hypertrophy During Antihypertensive Therapy Is 
Associated With Decreased Incidence of New-Onset 
Microalbuminuria: The LIFE Study     1028-194·A340
Rheumatoid Arthritis Is Independently Associated With 
Increased Left Ventricular Mass but Not Reduced Ejection 
Fraction     1023-31·A70
Should the Maze Procedure Be Utilized for Elimination 
of Atrial Fibrillation in Patients With Hypertrophic 
Cardiomyopathy?     1020-95·A273
Tumor Necrosis Factor Receptor 1 Level Is Associated With 
Left Ventricular Hypertrophy: The Northern Manhattan 
Study     1016-32·A60
Ventricular-Arterial Interactions Predict Survival in 6,762 
Patients With Left Ventricular Hypertrophy and Preserved 
Ejection Fraction     904-285·A132
Hypoxia
Continuous Positive Airway Pressure Therapy Reverses Latent 
Left Ventricular Longitudinal Dysfunction in Patients 
With Obstructive Sleep Apnea Syndrome: Demonstration 
by Two-Dimensional Speckle Tracking Echocardiography  
904-279·A131
Duration of Hypoxia During Sleep Is Associated With 
Increased Pulmonary Artery Systolic Pressure and 
Mortality     1035-176·A357
Soluble ST2 Plasma Concentrations Predict Mortality in 
Dyspneic Patients With Pulmonary Disease: Results From 
the ProBNP Investigation of Dyspnea in the Emergency 
Department (PRIDE) Study     1035-195·A362
Image processing, computer-assisted
Accurate Detection of Regional Contraction Using Novel 
Three-Dimensional Speckle Tracking Technique     
903-253·A116
Automated Quantitation of Regional LV Function on Gated 
Blood Pool SPECT is Superior to Visual Assessment 
of Wall Motion When Judged vs. Cardiac MR     
908-279·A168
Automatic Identification of Carotid Luminal Area Using 
Contrast-Enhanced Dual Energy CT     907-269·A155
Correlation Between Myocardial Fibrosis and Cardiac Sudden 
Death in Hypertrophic Cardiomyopathy     907-258·A152
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Enhancement of Nuclear Cardiac Laboratory Efficiency: 
Multicenter Evaluation of a New Postprocessing Method 
With Depth-Dependent Collimator Resolution Applied to 
Full and Half-Time Acquisitions     909-251·A170
In Acute Coronary Syndromes Thin Fibrous Cap and 
Ruptured Plaques Are Associated With Increased Local 
Inflammatory Activation: A Combination of Intravascular 
Optical Coherence Tomography and Intracoronary 
Thermography Study     1033-141·A265
Quantification of Mechanical Dyssynchrony: Comparison 
Between 2-Dimensional Speckle Tracking and Doppler 
Tissue Imaging Derivations     901-262·A100
Imaging
A Novel Gateway for Vascular Drug Delivery: Controlled 
Release of Nitric Oxide From Echogenic Liposomes     
1028-210·A344
Analysis of a New Automated Ejection Fraction Method 
in 64-Slice Computed Tomographic Angiography in 
Comparison to the Conventional Method and Its effect on 
Time Efficiency     906-279·A149
Application of Simultaneous Gd-153 Line Source Attenuation 
Correction to Half-Time Stress Only SPECT Acquisitions: 
A Multicenter Clinical Evaluation     909-257·A171
Bifunctional Targeting of Echogenic Immunoliposomes for 
Directed Stem Cell Delivery     1007-207·A288
Can We Speculate Thin Fibrous Cap Only by Virtual Histology 
Intravascular Ultrasound In Vivo?     1007-190·A285
Classification of the Postimplant Final Left Ventricular Lead 
Position: A Comparative Study Between Radiographic 
and Angiographic Modalities     1022-108·A24
Comprehensive Assessment of Coronary Artery Stenoses: CT 
Coronary Angiography Versus Conventional Coronary 
Angiography and Correlation With FFR     906-270·A147
Computational Simulations Demonstrate Altered Biomechanics 
in Postoperative Aortic Coarctation Patients     
1018-121·A90
Detection of Myocardial Infarction by Dual Source CT 
Coronary Angiography Using Quantitated SPECT as the 
Reference Standard     907-257·A152
Distribution of Myocardial Fibrosis in Scleroderma Patients: A 
Delayed-enhanced MRI Study     908-271·A166
Impact of Diabetes Mellitus on Intravascular Ultrasound 
Findings in Patients With Acute Myocardial Infarction 
With Plaque Ruptures     1010-76·A196
Impact of Stress SPECT Imaging After Revascularization: 
Evaluating the Appropriateness Criteria     1026-128·A256
Intraventricular Blood Flow Vorticity Reflects Left Ventricular 
Diastolic Dysfunction: Quantitative Assessment by 
Contrast Echocardiography Using Vector Particle Image 
Velocitimetry     904-258·A126
Noninvasive In Vivo Tracking Of Percutaneously 
Intramyocardially Injected Autologous Porcine 
Mesenchymal Stem Cells Modified for Transgene 
Expression of PET Reporter Gene Using Serial PET 
Imaging     1010-43·A189
Percutaneous Coronary Interventions for Chronic Total 
Occlusion: Novel Three-Dimensional Imaging and 
Quantitative Analysis     1026-149·A261
Plaque rupture and morphological characteristics of the culprit 
lesion in acute coronary syndromes without significant 
angiographic lesion: analysis by intravascular ultrasound     
1010-79·A197
Poor Reproducibility of Echocardiographic Measures of 
Mechanical Dyssynchrony in Cardiac Resynchronization 
Therapy (CRT)      804-8·A133
Prevalence of Obstructive Coronary Stenoses and the Need for 
Revascularization in Patients With Suspected Coronary 
Artery Disease and Zero Calcium Score: A Substudy of 
the CorE 64 Multicenter Trial     907-250·A151
Range of Normality of Echocardiographic Measures 
of Mechanical Synchrony in Healthy Individuals: 
Implication for a Multiparametric Approach in CRT 
Patients     905-259·A136
Real-Time Molecular Imaging Using Targeted Microbubble 
Ultrasound for Early Detection of Disease: A Step Closer 
Towards Application in Humans     904-252·A124
Relation Between Global Left Ventricular Longitudinal Strain 
Assessed by Automated Function Imaging and Left 
Ventricular Ejection Fraction     902-252·A106
Reporter Gene Imaging for Survival Monitoring of 
Transplanted Endothelial Progenitor Cells in the Rat 
Heart After Pretreatment With VEGF and Atorvastatin      
406-5·A374
Role of Myocardial Perfusion Imaging and Estrogen Status in 
Risk Stratification of Coronary Artery Disease in Women     
909-252·A170
Rubidium-82 Positron Emission Tomography Myocardial 
Perfusion Imaging - How accurate is it for detection of 
Multi-vessels disease?     909-263·A172
Serial Analysis of Neointimal Coverage Following Sirolimus-
Eluting Stent Implantation Using Optical Coherence 
Tomography: Comparison With Bare Metal Stent     
1031-66·A230
Strain Rate Imaging Demonstrates Long-Term Functional 
Improvement of Left Atrial and Left Ventricular Nonseptal 
Regions After Alcohol Septal Ablation in Obstructive 
Hypertrophic Cardiomyopathy     904-262·A127
Substantial Radiation Dose Reduction in 64-Multidetector 
Cardiac Computed Tomographic Angiography by Using 
Lower X-ray Energy During Scanning     906-276·A148
Underuse of Left Ventricular Function Assessment in Patients 
With Newly Diagnosed Heart Failure     1005-140·A238
Using Multidirectional Velocity Mapping to Improve Accuracy 
of the Proximal Isovelocity Surface Area Method of 
Quantifying Atrioventricular Valve Regurgitation: 
An In Vitro Magnetic Resonance Imaging Study     
908-260·A164
Utility of Multi-Detector Computed Tomography (MDCT) as a 
Diagnostic Triage Tool for Patients Presenting With Chest 
Pain to the Emergency Department: A MetAAnalysis     
906-256·A144
What Is the Prognostic Value of Myocardial Perfusion Imaging 
Using Rubidium-82 Positron Emission Tomography 
in Obese Patients With Known or Suspected CAD?     
909-265·A173
Immune suppression
Risk Factors for Relapse and Death in Patients With Cardiac 
Sarcoidosis: An 18 Year Experience of Corticosteroid 
Treatment     1023-3·A63
Role of Antiretroviral Therapy and HIV Infection in 
Atherosclerosis     1010-48·A190
Use of Disease-modifying Anti-rheumatic Drugs and 
Cardiovascular Events in Patients With Rheumatoid 
Arthritis     1035-230·A370
Immune system
A Novel EBV Encoded Protein Is Associated With ICAM 
Expression in Patients With Acute Myocardial Infarction     
1003-70·A185
Athero-Protective Effects of a Human ApoB-100 Related 
Peptide Vaccine in ApoE-/- Mice Are Modulated by 
Peptide Dose and Time of Initiation of High Fat Diet     
1028-207·A343
Candidate Genetic Variants in Fibrinogen, 
Methylenetetrahydrofolate Reductase and Intercellular 
Adhesion Molecule-1 Associated With Atherosclerosis 
and Their Baseline Plasma levels Among Various Race/
Ethnic Groups     1007-206·A288
Decreased Antibody Responses to Influenza Vaccine in Heart 
Failure Patients     1002-35·A42
Different Pathways of Innate and Adaptative Immunity in 
Type 1 and Type 2 Diabetes Mellitus Might Influence the 
Cardiovascular Risk     1007-228·A293
Do Selected Markers of Inflammatory Response During 
the Acute Phase of ST-Segment Elevation Myocardial 
Infarction Relate to Outcome?     1003-71·A185
Factor Analysis of Risk Variables Associated With Low-Grade 
Inflammation     1014-196·A302
Genetic Polymorphism T45G on Adiponectin Gene as a 
Risk Factor for Coronary Atherosclerosis: Effects on 
Adipokines Expression     1014-177·A298
Homocysteine Variations Induce Endothelial Dysfunction by 
Activating Endothelin-1 Pathway in Hypertensive Patients 
1028-219·A346
Humoral Activation in Human Heart Failure: A Potential 
Contributor for the Progression of Heart Failure     
1002-36·A42
Identification of T-Cell Proliferative Response to Cardiac 
Troponin I in Autoantibody-Positive Patients With 
Idiopathic Dilated Cardiomyopathy     1023-8·A64
Phagocytosis of Activated Platelets by Circulating Neutrophils 
in Acute Myocardial Infarction     1007-227·A293
Sex-Based Differences in Bone Marrow Progenitor Cell 
Depletion and Immune Response of Atherosclerosis: 
Viewing Atherosclerosis as a Disease of Failed 
Endogenous Repair     1007-230·A293
The Effect of Immune Modulation Therapy on Endothelial 
Function in Patients With Severe Chronic Heart Failure: 
Data From the Advanced Chronic Heart Failure Clinical 
Assessment of Immune Modulation Therapy (ACCLAIM) 
Trial     1009-9·A45
The Impact of Inflammatory Status on the Release of sCD40L 
in Coronary Atherosclerosis: Evidence for a Critical Role 
of the Underlying Disease State     1010-64·A194
Immunologic factors
Statin Treatment Improves 18-Months Survival In Patients 
With End-Stage Heart Failure     1028-161·A332
Tumor Necrosis Factor Antagonists and Methotrexate Improve 
Disease Activity and Decrease Aortic Stiffness in Patients 
With Rheumatoid Arthritis     1028-160·A332
Immunologic techniques
Plasmapheresis: A Potential Immunomodulatory Therapy 
for Patients With Nonischemic Cardiomyopathy     
1030-19·A76
Implants, artificial
Magnetically Targeted Cell Delivery Improves 30-Day 
Endothelialization of Synthetic Vascular Grafts     
1031-87·A234
Infarct size
A Degradation Product of GLP-1 Confers Protection Against 
Acute Myocardial Ischemia Reperfusion Injury in 
Diabetes Mellitus     1036-311·A378
A Novel Cardioprotective Medication After an Acute 
ST-Elevated Myocardial Infarction Decreases 
Proinflammatory Response and Stimulates Vascular 
Endothelial Growth Factor Release     1017-87·A210
Comparison of Delayed Enhancement Patterns on Multislice 
Computed Tomography Immediately After Coronary 
Angiography and Cardiac Magnetic Resonance Imaging 
in Acute Myocardial Infarction     906-284·A150
Comparison of Infarct Size and Cardiac Function in Patients 
With and Without Diabetes Mellitus After Primary 
Percutaneous Coronary Intervention for Acute Myocardial 
Infarction     1010-66·A194
Comparison of Randomized Early and Late Combined 
(Intramyocardial And Intracoronary) Treatment of 
Postischemic Ventricular Dysfunction With Bone 
Marrow-Derived Mononuclear Cells     1030-36·A80
COX-2 Inhibition With Parecoxib Abrogates Acute and 
Delayed Cardioprotective Effects of Sildenafil Against 
Ischemia/Reperfusion Injury      813-4·A223
Detection of Myocardial Infarction by Dual Source CT 
Coronary Angiography Using Quantitated SPECT as the 
Reference Standard     907-257·A152
Effects of Infarct Size on Left Ventricular Contractility and 
Preload: A Model Study     1023-15·A66
Effects on Myocardial Perfusion at Three and Fifteen Months 
in Recanalized Chronic Total Occlusions: Randomized 
Comparison of Blood-Derived Progenitor Cells and 
Inactive Serum     907-273·A156
Extent of Left Ventricular Scar Predicts Outcomes in 
Ischemic Cardiomyopathy Patients With Severe Systolic 
Dysfunction: A Delayed Hyper-Enhancement MRI Study      
812-7·A161
Greater Degree of LV Septal Hypertrophy and Associated 
Coronary Arteriole Dysplasia Are Significantly 
Associated With Myocardial Fibrosis in Hypertrophic 
Cardiomyopathy     1016-23·A58
Hydrogen Sulfide (H2S) Preconditions the Myocardium 
Against Myocardial IschemiAReperfusion Injury Via Up-
Regulation of Antiapoptotic Signaling     1010-41·A189
Increased Vulnerability to IschemiAReperfusion Injury in 
UCP3 Null Mouse Hearts     1003-74·A186
Intracoronary Compared With Intravenous Bolus Abciximab 
Application in Patients With ST-Elevation Myocardial 
Infarction Undergoing Primary Coronary Intervention     
806-7·A211
Low Radiation Prospectively ECG-Gated Multidetector 
Tomography Viability Imaging Correlates With Cardiac 
Troponin-I Serum Values Three Days Aafter Myocardial 
Infarction     907-271·A156
Myelosuppressives Improve Cardiac Dysfunction After 
Myocardial Infarction by Activating Cell Survival 
Signaling, Mobilizing CD34 Positive Cells and 
Attenuating Fibrosis and Apoptosis     1003-65·A183
Oral Glyburide, but Not Glimepiride, Blocks the Infarct-Size 
Limiting Effects of Pioglitazone     1003-41·A178
Phosphodiesterase-5 Inhibitors Reduce Myocardial Infarction, 
Apoptosis and Improve Post-Ischemic Ventricular 
Function in Female Mice     1003-43·A178
Prediction of Outcome of Surgical Ventricular Restoration 
Procedure in Patients With Congestive Heart Failure 
Utilizing Computer Simulation     1005-152·A241
Protein Kinase C-δ Inhibitor Protects Against Acute 
Myocardial Infarction by Intravenous Administration 
Either During Ischemia or Reperfusion     1003-86·A188
Ranolazine’s Mechanism of Action for Reducing Myocardial 
Infarct Size Is Independent of Changes in Coronary 
Collateral Blood Flow     1003-60·A182
Real-Time Magnetic Resonance Imaging (MRI) of the 
Time Course of Myocardial Injury and Cell Death in a 
Canine Model of Regional Ischemia and Reperfusion     
1003-75·A186
Resolvin E1 Protects the Rat Heart Against Reperfusion Injury   
1003-42·A178
Spatial Distribution of Intraventricular Dyssynchrony in 
Relation to Infarct Location: a Cardiovascular Magnetic 
Resonance Tissue Synchronization Mapping Study     
907-280·A158
Strain Rate Dobutamine Analysis in Subacute Phase of the 
Myocardial Infarction Predicts Transmural Necrosis as 
Assessed Cardiac Magnetic Resonance     905-261·A136
Time to Reperfusion Correlates to Transmural Extent Rather 
Than Infarct Size in Primary Percutaneous Coronary 
Angioplasty: Contrast-Enhanced Magnetic Resonance 
Imaging Analysis     908-259·A164
Usefulness of C-Reactive Protein in Detecting Higher Risk 
Patterns of Myocardial Infarction Defined by Contrast 
Enhanced Magnetic Resonance Imaging     908-251·A162
Information technology
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Differential Impact of Telemedicine on Exercise Capacity 
and Body Composition in Urban and Rural Underserved 
Populations     1005-155·A242
Insulin
A Novel Porcine Model of Diet-Induced Obesity Causes 
Deranged Myocardial Insulin Signaling     1021-200·A321
Does Routine Assessment of Insulin Sensitivity Identify Type 
2 Diabetic Patients With High Cardiovascular Risk?     
1028-224·A347
Impact of Hyperinsulinemia on Tissue Characteristics of 
Nonculprit Plaque in Nondiabetic Patients With Acute 
Coronary Syndrome     1028-159·A332
Insulin-Like Growth Factor-1 Receptor Expression Regulates 
Insulin Sensitivity of Vascular Smooth Muscle Cells     
1028-199·A341
Is Insulin Resistance or Obesity a Hypercoagulable State?     
1014-223·A308
Telmisartan Prevents In Vitro the Adverse Effects of Protease 
Inhibitors on Adipocyte Functions     1021-205·A322
Integrated delivery systems
Coordinated Inter-Hospital Transfer Program Improves 
Quality of Care Delivered to ST Elevation Myocardial 
Infarction Patients Presenting in Rural Communities     
1017-75·A207
Intravascular ultrasound/doppler
Accuracy of 64-Slice Computed Tomography for the Definition 
of the Atherosclerotic Coronary Plaque: Comparison 
With Coronary Artery Angiography and Intravascular 
Ultrasound     1031-54·A227
Accuracy of Dual-Source Computed Tomography in the 
Assessment of Plaque Morphology: Use of Quantitative 
Plaque Analysis Software in Comparison to IVUS Virtual 
Histology     905-275·A139
Adaptive Remodeling of Culprit Artery Following Sirolimus 
Eluting Stent Implantation in Acute Myocardial 
Infarction: Its Effect on Late Stent Malapposition     
1010-53·A191
Comparison Between Three-Dimensional Angiographic 
Reconstruction and Intravascular Ultrasound Imaging 
for the Measurement of Intracoronary Cross-Sectional 
Luminal Dimensions     1031-61·A229
Coronary Plaque Assessment With Multi-Slice Computed 
Tomography and Virtual Histology Intravascular 
Ultrasound in Symptomatic Patients With Type 2 Diabetes 
905-279·A140
Does the Presence of the Metabolic Syndrome Accelerate 
Progression of Cardiac Allograft Vasculopathy? A 
Serial Volumetric Intravascular Ultrasound Study     
1030-32·A79
Does Tissue Characteristics Differ Between Proximal 
and Distal Segment of Left Anterior Descending 
Coronary Artery in Angina Pectoris? An Integrated 
Backscatter Intravascular Ultrasound (IB-IVUS) Study     
1007-213·A290
Echocardiography to Guide Transcatheter Left Ventricular 
Reconstruction (Dor Procedure) in an Ovine Model of 
Chronic Left Apical Aneurysm: Preliminary Qualitative 
and Quantitative Results     903-259·A117
Effect of Lipid Lowering Therapy on Progression of 
Intermediate Coronary Atherosclerotic Plaque 
Evaluated by Virtual Histology Intravascular Ultrasound     
1021-227·A328
Impact of Arterial Injury on Neointimal Hyperplasia After 
Implantation of Drug-Eluting Stents in Coronary Arteries: 
An Intravascular Ultrasound Study     1026-139·A259
Impact of Atherogenic Lipids on Progression of Coronary 
Atherosclerosis in Patients With High Levels of HDL 
Cholesterol     814-8·A351
Impact of Hyperinsulinemia on Tissue Characteristics of 
Nonculprit Plaque in Nondiabetic Patients With Acute 
Coronary Syndrome     1028-159·A332
Increased Volumetric Error in Intravascular Ultrasound 
(IVUS) Plaque Measurements of Curved Coronary Artery 
Subsegments     902-276·A112
Intravascular Imaging Using Combined Intravascular 
Ultrasound and Photoacoustic Catheters in a Rabbit 
Atherosclerotic Model     1031-85·A234
Is Contrast-Enhanced 64-Slice Computed Tomography an 
Alternative to Quantitative Coronary Angiography in 
Ambiguous Lesions?     906-275·A148
Linear Relation Between Plaque Vulnerability and the Balance 
of n6/n3 Polyunsaturated Fatty Acids: A Study of Stable 
Angina Pectoris With Radiofrequency Intravascular 
Ultrasound     1014-216·A307
Natural History of the Thin Cap Fibroatheroma Assessed by 
Optical Coherence Tomography In Vivo     1010-83·A197
Nonuniform Struts Distribution as the New Potential 
Mechanism of Stent Thrombosis After Drug-Eluting Stent 
Implantation     1010-46·A190
Pitfalls in Multidetector Computed Tomography and 
Quantitative Coronary Angiography Evaluation of Left 
Main Coronary Artery Disease: Ostium Lesions, Short 
Lesions, and Heavy Calcification      812-6·A161
Relation Between Coronary Angiographic Lesion Morphology 
and Virtual Histology Intravascular Ultrasound Plaque 
Properties     903-255·A116
Relationship Between Longitudinal Morphology of Ruptured 
Plaques and TIMI Flow Grade in Acute Coronary 
Syndrome: A Three-Dimensional Intravascular Ultrasound 
Imaging Study     1010-72·A195
Relationship Between Management of Serum Lipid Levels 
and Vulnerability of Coronary Plaque: An Investigation 
Wwith In Vivo Tissue Characterization Using Integrated 
Backscatter-Intravascular Ultrasound     1035-212·A366
SPIRIT II Study: A Clinical Evaluation of the XIENCE 
V Everolimus Eluting Coronary Stent System in the 
Treatment of Patients With De Novo Native Coronary 
Artery Lesions     1026-147·A261
Investigational devices
A Novel Ventricular Elastic Support System Reverses 
Remodeling in Heart Failure Patients     1030-11·A74
Does Lowering Filling Pressures by Using Continuously 
Measured Intracardiac Pressures Result in Reduced Risk 
of Heart Failure Event?     1030-39·A80
Intravascular Stents Electroplated with 117mSn Reduce 
Arterial Wall Inflammation in Hyperlipidemic Rabbits     
1021-202·A322
Pilot Study of a Novel Percutaneous Treatment Strategy 
for Hypertrophic Obstructive Cardiomyopathy     
1016-28·A59
Investigational drugs
BAY 58-2667, a Soluble Guanylate Cyclase Activator, 
Improves Cardiopulmonary Hemodynamics in Acute 
Decompensated Heart Failure and Has a Favorable Safety 
Profile     1009-8·A45
Efficacy and Safety of a Novel Fibrate, ABT-335, in 
Combination With Atorvastatin in Patients With 
Mixed Dyslipidemia: A 12-week Phase 3 Study     
1021-222·A327
Efficacy and Safety of a Novel Fibrate, ABT-335, in 
Combination With Simvastatin in Patients With Mixed 
Dyslipidemia: A Phase Three Study     1021-223·A327
Inhibition of Plaque Neovascularization and Intimal 
Hyperplasia by Specific Targeting Vascular Endothelial 
Growth Factor With Bevacizumab-Eluting Stent: An 
Experimental Study     1033-134·A264
Novel Pharmacological Compounds as Triggers of 
Preconditioning In Vivo     1003-64·A183
Ion channels
Molecular Basis of the Inhibition of Cardiac IK1 Current by 
Protein Kinase C: Role of PKC Beta and Kir2.x Channel 
Subunit Heterogeneity     1001-92·A1
Role of Sterol Regulatory Element Binding Protein (SREBP) 
in the Regulation of the Parasympathetic Response and 
Inducible Ventricular Arrhythmia     1001-107·A4
The Effects of Chiral Isolates of Methadone on HERG Current   
1001-90·A1
The KATP Channel as a Target to Improve the Senescent Heart’s 
Response to Stress     1021-206·A322
Thiazolidinedione Drugs Block Cardiac KATP Channels and 
May Increase the Propensity for Ischemic Ventricular 
Fibrillation in Pigs     1015-97·A16
Variability in Risk With Different Hot Spot Mutations 
Involving the LQT1-KCNQ1 Gene      811-8·A28
Ion currents
Molecular Basis of the Inhibition of Cardiac IK1 Current by 
Protein Kinase C: Role of PKC Beta and Kir2.x Channel 
Subunit Heterogeneity     1001-92·A1
Ranolazine’s Mechanism of Action for Reducing Myocardial 
Infarct Size Is Independent of Changes in Coronary 
Collateral Blood Flow     1003-60·A182
Ischemia
ß1-Adrenergic Receptor Polymorphism Predicts Mental Stress-
Induced Myocardial Ischemia in Patients With Coronary 
Artery Disease     1036-306·A377
A Novel Therapeutic Angiogenesis With Sustained Delivery 
Form of Platelet-Rich Plasma in Mouse Hind Limb 
Ischemia Model     1021-162·A312
Accurate Detection of Coronary Artery Disease Without Use 
of Radiation Using Non-stress Magnetocardiography     
1031-72·A231
Adult Bone Marrow Cells Differentiate Into Multiple 
Structures and Trigger Angiogenesis Expression in ApoE 
Knockout Mice     1014-224·A308
Angina, Open Arteries and Endothelial Dysfunction in Women 
With Suspected Ischemia     1021-189·A319
Can We Speculate Thin Fibrous Cap Only by Virtual Histology 
Intravascular Ultrasound In Vivo?     1007-190·A285
Cardiac Magnetic Resonance Imaging and Coronary Reactivity 
Testing: A Useful Noninvasive Tool     1031-71·A231
Cardiac Resident Stem Cells Exhibit Mesenchymal Features 
and Provide No Long-Term Benefit to Cardiac Function in 
Mouse Ischemic Model of Heart Failure      406-8·A375
Chromogranin A Levels in the Acute Phase Independently 
Predicts Mortality and Heart Failure Hospitalizations 
During Follow-Up in Patients With Non-ST Elevation 
Acute Coronary Syndromes     1024-85·A222
Clinical Outcomes in Patients With Advanced Limb Ischemia     
1028-182·A337
Combined Quantitative Analysis of 64-Slice Coronary 
CT Angiography and Myocardial Perfusion SPECT     
909-264·A173
Comparison Between Myocardial Perfusion Scintigraphy, 
Exercise Stress Test and Cardiopulmonary Stress 
Test in the Assessment of Severe Coronary Artery 
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With Exercise Best Predicts Survival After Aortic Valve 
Replacement for Chronic Severe Aortic Regurgitation     
1006-96·A271
Prognostic Impact of Myocardial Perfusion Score Versus 
Wall Motion Score Index in Grading the Likelihood 
of Cardiovascular Events Following an Abnormal 
Dobutamine Stress Echocardiogram     904-251·A124
Prognostic Implications of Platelet Function Parameters 
Assessed Using Standard Optical Aggregometry 
In Patients With Type Two Diabetes Mellitus     
1007-176·A282
Prognostic Markers of Perioperative Cardiac Outcomes 
Among Patients Undergoing Liver Transplant Surgery     
903-270·A120
Progression of Coronary Atherosclerosis in Statin Treated 
Patients With Hypertriglyceridemia     1028-170·A334
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909-265·A173
Oxygen consumption
Direct Blood-Sampling From the Coronary Collateral 
Circulation Provides New Insights in Human Collateral 
Artery Growth     1014-215·A306
Role of Oxygen and ROS in Bone Marrow Derived Progenitor 
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Extent of Inotropic Contractile Reserve Predicts 
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Apoptosis and Improve Post-Ischemic Ventricular 
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Renal Molecular Remodeling After Myocardial Infarction 
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Survival With and Without Transplantation in Advanced 
Idiopathic Pulmonary Arterial Hypertension      
803-9·A311
The Effects of Intracoronary CD34+ Stem Cell Transplantation 
In Patients With End-Stage Dilative Cardiomyopathy      
819-8·A82
Tricuspid regurgitation
Fate of Functional Tricuspid Regurgitation in Adults After 
Closure of Atrial Septal Defects Without Any Tricuspid 
Valve Procedures     1032-122·A96
Geometric Changes After Tricuspid Annuloplasty and 
Determinants of Residual Significant Tricuspid 
Regurgitation: A Real-Time Three-Dimensional 
Echocardiography Study     903-250·A115
Impact of Transvenous Ventricular Pacing Leads on Tricuspid 
Regurgitation in Pediatric and Congenital Heart Disease 
Patients     1015-113·A19
Novel Technique of Atrioventricular Septal Pacing Promotes 
Ventricular Synchrony Without Crossing the Tricuspid 
Valve      802-4·A13
Real-Time Three-Dimensional Echocardiography Provides 
New Insight Into the Mechanisms of Tricuspid Valve 
Regurgitation in the Patient With Hypoplastic Left Heart 
Syndrome     1011-120·A87
Troponin
Prevalence and Prognostic Significance of Pre-Procedure 
Cardiac Troponin Elevation Among Patients With Stable 
Coronary Artery Disease Undergoing Percutaneous 
Coronary Intervention: Results From the EVENT Registry 
1026-146·A260
Remote Ischemic Preconditioning in Humans Attenuates 
Procedure-Related Cardiac Troponin-I Release After 
Elective Percutaneous Coronary Intervention: A Single-
Center Randomized Controlled Trial     1017-65·A205
The Prevalence and Prognostic Value of Cardiac Troponin T 
Elevation in Ambulatory Patients With Stable Coronary 
Artery Disease     1036-309·A378
Ultrasonic diagnosis
Framingham Risk Score Is Associated With Femoral Artery 
IntimAMedia Thickness in Asymptomatic Young Adults: 
The Bogalusa Heart Study     1007-189·A285
Left Ventricular Rotation, Twist, and Torsion in Hypertrophic 
Cardiomyopathy: New Insights from Ultrasound Tissue 
Tracking and Imaging     905-262·A137
Microvascular Complications in Type 2 Diabetes Are 
Associated With Abnormal Skeletal Muscle Capillary 
Responses to Low and High-Intensity Exercise      
804-6·A133
Plaque rupture and morphological characteristics of the culprit 
lesion in acute coronary syndromes without significant 
angiographic lesion: analysis by intravascular ultrasound     
1010-79·A197
Prevalence and Distribution of Subclinical Atherosclerosis by 
Screening Vascular Ultrasound in a Low and Intermediate 
Framingham Risk Cohort     1035-190·A361
Prevalence and Predictors of Carotid Versus Femoral Plaque by 
Screening Vascular Ultrasound in Asymptomatic Adults     
1014-194·A302
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Quantitative Contrast-Enhanced Ultrasound Imaging of the 
Carotid Artery Vasa Vasorum: Calibration and Initial 
Results     1021-184·A318
Real-Time 3-Dimensional Echocardiographic Quantification 
of Left Ventricular Volumes: Multicenter Study for 
Validation With Magnetic Resonance Imaging and 
Investigation of Sources of Error     902-270·A111
Real-Time Molecular Imaging Using Targeted Microbubble 
Ultrasound for Early Detection of Disease: A Step Closer 
Towards Application in Humans     904-252·A124
Structural Abnormalities in Thoracic Aortic Aneurysm 
Associated With Bicuspid Aortic Valve Can Be 
Identified Noninvasively by Quantitative Ultrasound     
904-277·A130
The Resistive Index in Renal Peripheral Arteries Predicted 
Future Renal Dysfunction in Elder Patients     809-8·A350
Validation of Renal Duplex Ultrasound in Detecting Renal 
Artery Stenosis Post-Stenting     1021-180·A317
Unstable angina
A Propensity Score Analysis of the Benefit of Upstream 
Platelet Glycoprotein IIb/IIIa Receptor Antagonists in 
Acute Coronary Syndromes--Insights From the TRACS 
Registry     1017-42·A199
An Invasive Management Strategy Is the Only Therapeutic 
Intervention Associated With Improved Survival in Acute 
Coronary Syndrome Complicated by Hemodynamic 
Compromise     1010-77·A197
Anemia Is Associated With Increased One-Year Mortality 
and Ischemic Events in Patients With Acute Coronary 
Syndromes: Results From the ACUITY Trial     
1024-75·A220
Does an Early Invasive Strategy in NSTEMI Management 
Result in Long-Term Benefit?     1010-71·A195
Does Continuous ST-Segment Monitoring Add Prognostic 
Information to the TIMI, PURSUIT, and GRACE Risk 
Scores?     1024-84·A222
Does the Pattern of Serial Values of C-Reactive Protein Predict 
Outcome in Patients With Acute Coronary Disease? The 
RISCA Study     1024-70·A219
Early Phase of Gadolinium Enhancement and T2-Weighting 
Imaging on Cardiac Magnetic Resonance Can Detect 
Ischemic Stunned Myocardium     1010-84·A198
Economic Evaluation of Bivalirudin With or Without 
Glycoprotein IIB/IIIA Inhibition Versus Heparin With 
Routine Glycoprotein IIB/IIIA Inhibition for Early 
Invasive Management of Acute Coronary Syndromes     
1024-71·A219
Efficacy and Safety of Ranolazine in Chronic Angina: 
Observations From the Randomized, Double-
blind, Placebo-Controlled MERLIN-TIMI 36 Trial     
1031-45·A225
High Density Lipoprotein Cholesterol Is a Strong Independent 
Predictor of All-Cause Mortality in the Non-ST Segment 
Elevation Acute Coronary Syndrome     1024-61·A217
Increased Mortality in Patients With Acute Coronary 
Syndromes and Delay to Angioplasty of Greater Than 24 
Hours After Hospital Admission: An ACUITY Substudy     
1024-56·A215
Lack of Impact of Randomized Trials on Percutaneous 
Coronary Intervention (PCI) Practice: Data From the 
American College of Cardiology National Cardiovascular 
Data Registry (ACC-NCDR)     1005-128·A236
Long-Term Compliance With Guideline-Based Medical 
Therapies Is the Strongest Predictor of Event Free 
Survival Following Acute Coronary Syndromes (ACS) 
and Myocardial Infarction (MI)     1010-87·A198
Major Bleeding Is Associated With Increased One-Year 
Mortality and Ischemic Events in Patients With Acute 
Coronary Syndromes: Results From the ACUITY Trial     
1024-73·A219
Myocardial Edema in Patients With Non-ST Elevation Acute 
Coronary Syndrome Predicts Coronary Revascularization 
Strategy     908-262·A164
Noninvasive Diagnosis of Acute Coronary Syndrome Among 
Patients With Chest Pain by Echocardiographic Detection 
of Postischemic Regional Left Ventricular Diastolic 
Dyssynchrony Using Strain Image Derived From 2D 
Speckle Tracking     901-280·A104
Polymorphism of Endothelial NOS Gene Promoter Is 
Associated With Endothelial Dysfunction, Increased 
Arterial Stiffness and Has Negative Prognostic Impact 
After ACS     1010-88·A199
Predictors of Benefit Using an Early Invasive Strategy in 
the Management of Unstable Angina/Non ST-Elevation 
Myocardial Infarction     1010-67·A194
Reduced Benefit of Delayed Coronary Artery Bypass Graft 
Surgery in Acute Coronary Syndromes     1010-61·A193
Revascularization but Not Early Invasive Management Is 
Associated With a Good Prognosis in Patients With 
Non-ST-Segment Elevation Acute Coronary Syndrome     
1010-58·A192
Sex-Based Differences in Mortality Following Acute Coronary 
Syndromes     1010-65·A194
The Consequences of Major Bleeding in Acute Coronary 
Syndromes     1026-133·A257
The Impact of Inflammatory Status on the Release of sCD40L 
in Coronary Atherosclerosis: Evidence for a Critical Role 
of the Underlying Disease State     1010-64·A194
The TRACS Score Predicts Benefit of Upstream 
Glycoprotein IIb/IIIa Use in Acute Coronary Syndromes     
1017-43·A199
Timing of Coronary Artery Bypass Grafting Following Non-
ST-Elevation Acute Coronary Syndrome and Mortality     
1010-55·A192
Transfusion Is Associated With Increased One-Year 
Mortality and Ischemic Events in Patients With Acute 
Coronary Syndromes: Results From the ACUITY Trial     
1024-74·A220
Treatment and Outcome of Diabetic Patients With an Acute 
Coronary Syndrome: Has There Been Any Improvement 
Over Time? The GRACE Registry     1012-134·A244
Valvular disease
Aortic Valve Bypass Surgery for the High-Risk Patient With 
Aortic Stenosis     1027-82·A274
Clinical Implications of Aortic Atherosclerosis Evaluated by 
Transesophageal Echocardiography in Surgery of Patients 
With Valvular Heart Diseases     1014-226·A309
Congenital Vascular Ring Abnormalities Are Associated With 
Reversible Lower Intellectual Performance in School 
Aged Children: Potential Impact of Early Diagnosis and 
Intervention     1018-126·A91
Does Coronary Artery Bypass Surgery Combined With Aortic 
Valve Replacement Increase the Risk of Surgery in 
Patients > 80 Years Old?     1013-95·A272
Ebstein Anomaly and Left Ventricular Dysfunction: Effect of 
Tricuspid Valve Operation     808-5·A94
Minimally Invasive Approach for Aortic Valve Replacement in 
The Elderly Is Associated With Lower Mortality: A Case 
Matched Study     1006-81·A271
Mitral Valve Tenting, but Not Mitral Annular Enlargement 
Determine Severity of Functional Mitral Regurgitatio: A 
Quantitative Full Volume 3-D Echocardiography Analysis   
903-257·A117
PON1 Genotype Correlates With Increased Risk of Aortic 
Stenosis Progression      816-4·A276
Preoperative Wall-Stress-Adjusted Ejection Fraction Change 
With Exercise Best Predicts Survival After Aortic Valve 
Replacement for Chronic Severe Aortic Regurgitation     
1006-96·A271
Quantitative Three-Dimensional Evaluation of Aortic-
Mitral Coupling Using the New Transesophageal 
Echocardiographic Matrix Array Transducer     
902-275·A112
Reoperation After the Ross Procedure: Spectrum, Challenges, 
and Outcome     1032-119·A95
The Ross-Konno Procedure: Intermediate-Term Clinical and 
Echocardiographic Follow-Up     1025-122·A92
Underestimation of the Prevalence of Multiple Lesions 
in Patients With Papillary Fibroelastoma: An 
Echocardiographic and Surgical Prospective Study     
902-268·A110
Valvuloplasty
Comparison of Clinical Outcomes of Mitral Valve Repair 
in Patients With Myxomatous Degenerative Versus 
Rheumatic Mitral Regurgitation     1020-81·A273
Geometric Changes After Tricuspid Annuloplasty and 
Determinants of Residual Significant Tricuspid 
Regurgitation: A Real-Time Three-Dimensional 
Echocardiography Study     903-250·A115
Mitral Valve Repair With Artificial Chordae: Is Prolapse 
Localization an Independent Risk Factor in Degenerative 
Disease?     1027-96·A274
Vascular biology
Senescent Vascular Smooth Muscle Cells Play an Important 
Role in the Formation of Vascular Calcification      
406-6·A374
A Novel EBV Encoded Protein Is Associated With ICAM 
Expression in Patients With Acute Myocardial Infarction     
1003-70·A185
Anti-Apoptotic Effects of Erythropoietin in Human Vascular 
Endothelial Cells     1007-188·A284
B-Type Natriuretic Peptide Enhances Vasculogenesis by 
Promoting the Number and Functional Properties of 
Endothelial Progenitor Cells     1007-218·A291
Bone Marrow Progenitor Cell Stores Impact Circulating 
EPC Levels and Are Depleted in Elderly Subjects     
1014-199·A303
Chemokine Upregulation in the Aortic Vasa Vasorum Is 
Associated With Inflammatory Cell infiltration and 
Aneurysmal Dilation of the Aorta     1014-227·A309
Circulating Endothelial Progenitor Cell Activity as a Predictor 
of Cardiovascular Outcomes     1014-206·A305
Circulating Levels of Soluble Form of LR11, A Novel 
Migration Regulator of Intimal SMC, Are Increased in 
Subjects With Coronary Stenosis     1014-168·A296
Depletion of CD133/KDR Endothelial Progenitor Cell 
Correlates With the Presence of Coronary Atherosclerosis 
in Patients With Rheumatoid Arthritis     1007-211·A289
Erythropoietin Stimulates Normal Endothelial Progenitor 
Cell-Mediated Endothelial Turnover, but Attributes 
to Neovascularization Only in the Presence of Local 
Ischemia     1007-224·A292
Exploring the Links Between Low-Grade Inflammation, 
Endothelial and Cardiorenal Dysfunction: The Role of 
Asymmetric Dimethylarginine in Essential Hypertension     
1007-163·A279
Factors Influencing Arterial Stiffness in HIV Infected Patients     
1035-178·A358
Human Adipose Tissue-Derived Stem Cell Preserved Heart 
Function in Athymic Nude Rats Following Permanent 
Ischemia     1010-45·A190
Identification of the Patient Requiring Revascularization 
by Multianalyte Profiling Analysis: A Blueprint 
Characterized by Heightened Inflammation and 
Endothelial Dysfunction     1014-218·A307
Insulin-Like Growth Factor-1 Receptor Expression Regulates 
Insulin Sensitivity of Vascular Smooth Muscle Cells     
1028-199·A341
Inter-Relationships of Arterial Stiffness With Asymmetric 
Dimethylarginine, Endothelin-1 and Adiponectin in 
Essential Hypertension     1007-183·A283
Inter-Relationships of Asymmetric Dimethylarginine With 
Urinary Albumin Excretion and Low-Grade Inflammation 
in Essential Hypertension     817-7·A371
Interrelationships of Urinary Albumin Excretion With 
Endothelin-1 and Arterial Stiffness in Essential 
Hypertension: An Integrative Approach to Vascular 
Dysfunction     1007-193·A286
Lnk Gene Deficiency Contributes to Cardiac Repair Post 
Myocardial Infarction by Equivalently Enhancing 
Regenerative Capacity of BM-Derived Progenitor 
Cells and Resident Cardiac Stem/Progenitor Cells     
1003-56·A181
Obesity Increases Vascular Senescence and Susceptibility 
to Ischemic Injury Through Chronic Activation of Akt/
mTOR      402-6·A372
Overlapping Traits in Carriers of Mutations of the TGFBR1 
and TGFBR2 Genes Associated With Marfan Syndrome 
Type II, Loeys-Dietz Syndrome and Familial Thoracic 
Aortic Dilation/Dissection     1014-217·A307
Plasma Redox State and the Recurrence of Atrial Fibrillation     
1015-89·A14
Possible Role of Somatic Mitochondrial Mutations in the 
Development of Atherosclerotic Lesion of Human Aorta     
1007-192·A285
Reappraisal of the Role of Uric Acid in Essential Hypertension: 
Cross-Sectional Relationships With Subclinical 
Inflammation, Adiponectin and Arterial Stiffness     
1028-179·A336
Refractory Angina Is Associated With Increased Arterial 
Stiffness and Elevated Wave Reflection Amplitude     
1031-53·A227
The Haptoglobin 2 Genotype Is Associated With Increased 
Redox Active Hemoglobin Derived Iron in the 
Atherosclerotic Plaque     1007-181·A283
The Platelet P2Y12 Receptor Influences the Vessel 
Wall Response to Arterial Injury and Thrombosis     
1007-220·A291
Urine Proteome Patterns Can Identify Coronary Artery Disease  
1007-174·A281
Vascular Dysfunction Is a Determinant of Carotid Wall 
Volume: Atherosclerosis and Arteriosclerosis Quantified 
by MRI     908-254·A163
Ventricular-Arterial Interactions Predict Survival in 6,762 
Patients With Left Ventricular Hypertrophy and Preserved 
Ejection Fraction     904-285·A132
Vascular surgery
Clinical Outcomes in Patients With Advanced Limb Ischemia     
1028-182·A337
Coronary Artery Revascularization Versus Medical 
Management Before Elective High-Risk Noncardiac 
Surgery: A MetAAnalysis     1019-148·A254
Distal Aortic Growth in Marfan’s Syndrome: Comparison 
Between Patients With and Without Elective Surgery 
of the Aortic Root Using Magnetic Resonance Imaging     
1021-164·A313
Large-Scale Screening and Outcome of Complete Vascular 
Rings: A Prospective Study in 186,213 School-Aged 
Children     1011-126·A89
Vasoconstriction
A Role for RhoA/Rho-Kinase in Particulate Air Pollution 
Mediated Cardiovascular Changes     1028-198·A341
Endothelial Serum Markers, Serum Uric Acid and 
Lipoprotein (a), Correlate With Activity of Vasospasm     
1014-191·A301
Long-Term Clinical Prognosis of Provocation Positive Variant 
Angina     1012-156·A249
Vasodilation
Additional Novel Advantage of Carvedilol as a Prevention 
of Nitrate Tolerance via Attenuating Depletion of 
Cytochrome P450     1007-173·A281
Effect of Bosentan on Patients With Eisenmenger Syndrome     
1032-117·A94
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Functional Polymorphism in the COMT Gene Predisposes to 
Perioperative Vasoplegia     1013-96·A272
IntrAArterial Nitrite Causes an Enduring Vasodilation in Man     
1007-184·A284
Normal Individuals Who Do Not Increase Arterial Load 
During Exercise Have a Higher Long Term Mortality     
909-272·A174
Vasodilator agents
BAY 58-2667, a Soluble Guanylate Cyclase Activator, 
Improves Cardiopulmonary Hemodynamics in Acute 
Decompensated Heart Failure and Has a Favorable Safety 
Profile     1009-8·A45
SR123781A, a New Synthetic Anticoagulant for the Prevention 
of Venous Thromboembolism in Total Hip Replacement 
Surgery - DRIVE: A Dose Ranging Study      803-4·A310
Vasopressin
A Novel Vasopressin Antagonist Like Peptide With Potent 
Aquaretic Natriuretic, Cardiac Unloading Properties, and 
Preservation of Blood Pressure     1021-207·A323
Ventilation
Factors Associated With the Improvement of Left Ventricular 
Systolic Function by Continuous Positive Airway Pressure 
in Patients With Heart Failure and Obstructive Sleep 
Apnea     1030-27·A78
Ventricular arrhythmia
Anger, Alternans, and Arrhythmia: Anger-Induced TWA 
Predicts Future Ventricular Arrhythmias in Patients With 
ICDs     1029-109·A32
Could Autologous Bone Marrow Transplant for Myocardial 
Regeneration Decrease Cardiovascular Risk and 
Mortality?     1030-21·A76
Evaluation of Microvolt T-Wave Alternans Test Result 
Concordance Over Time in the MASTER Trial     
1015-106·A17
ICD Patients With Electrical Storm: Clinical Characteristics, 
Concomitants and Outcome in a Single Center     
1022-112·A25
Implantable Cardioverter-Defibrillator Outcomes in Cocaine 
Abusers     1029-89·A28
Improved Risk Stratification by Tissue Doppler Imaging 
in High Risk Patients With Long QT Syndrome     
1015-100·A16
Incidence of Ventricular Arrhythmias in Ischemic Secondary 
Prevention ICD Recipients: Long-term Follow-Up 
of the Leiden Out-of-Hospital Cardiac Arrest Study     
1015-98·A16
Limited Relevance of Invasive Electrophysiologic Testing 
in Patients Meeting Current Primary Prevention 
Indications for an Implantable Cardioverter-Defibrillator     
1022-114·A26
Mapping and Ablation of Frequent Post-Infarction Premature 
Ventricular Complexes     1015-108·A18
Microvolt T-Wave Alternans and Electrophysiological Testing 
Predict Different Arrhythmia Outcomes: Lessons From 
the Alternans Before Cardioverter Defibrillator (ABCD) 
Trial     1015-110·A18
Mortality Risk Increases for Each Subsequent Ventricular 
Arrhythmia Treated With an ICD Shock: Results 
From the Sudden Cardiac Death in Heart Failure Trial     
1015-112·A19
MRI Findings in Idiopathic Outflow Tract Arrhythmias: A 
Reappraisal     1015-99·A16
No Difference in ICD Treated Ventricular Arrhythmias in 
Patients With Left Ventricular Ejection Fraction of 31-35 
% Compared to ≤ 30 %     1022-115·A26
Nonsustained Ventricular Tachycardia as a Predictor of Sudden 
Death in Heart Failure: A MetAAnalysis     1029-111·A33
Prognostic Value of Microvolt T-wave Alternans in Patients 
With Moderate Ischemic Left Ventricular Dysfunction: 
Results From the MASTER II Trial     1015-105·A17
Role of Sterol Regulatory Element Binding Protein (SREBP) 
in the Regulation of the Parasympathetic Response and 
Inducible Ventricular Arrhythmia     1001-107·A4
Search for Cardiac Calcium Cycling Gene Mutations 
in Familial Ventricular Arrhythmias Resembling 
Catecholaminergic Polymorphic Ventricular Tachycardia     
1015-109·A18
Statin Therapy and Exercise Induced Ventricular Arrhythmias     
909-270·A174
Ventricular fibrillation
A Prospective Randomized Comparison of Defibrillation 
Thresholds From the Right Ventricular Apex and Outflow 
Tract     1029-94A·A29
Chemical Ablation of Subendocardium and Purkinje Fibers 
in Dogs Causes Early Termination and Activation Rate 
Slowing of Long Duration Ventricular Fibrillation     
1001-108·A4
Defibrillation Threshold Decreases With Repeated Episodes of 
Long Duration Fibrillation     1031-73·A232
Effects of Verapamil Suggest that Calcium Current Is 
Important in Maintaining Ventricular Fibrillation Lasting 
More Than Three to Four Minutes     1001-89·A1
Heart Failure Patients Have Drops in Intrathoracic 
Impedance Preceding Ventricular Fibrillation Episodes      
405-9·A374
Impact Energy Does Not Alter Narrow Time Window of 
Vulnerability in Ventricular Fibrillation (Commotio 
Cordis)     1001-93·A1
Is J-Point Elevation a Specific Electrocardiographic Marker of 
Idiopathic Ventricular Fibrillation?     1015-104·A17
Left Ventricular Structural Remodeling Increases Cardiac 
Electrical Stability in Exercised Rat     1001-94A·A2
Susceptibility to Ventricular Fibrillation Produced by Chest 
Blows (Commotio Cordis) Is Related to the Length of the 
QT Interval     1015-101·A17
The P-Selectin Gene Polymorphism val168met: A Novel 
Risk Marker for the Occurrence of Primary Ventricular 
Fibrillation During Acute Myocardial Infarction     
1001-91·A1
Transmural Propagation of Wavefronts During Long Duration 
Ventricular Fibrillation     1001-103·A3
Ventricular function
A New Speckle Tracking Algorithm Can Accurately Analyze 
Left Ventricular Wall Motion - A Multicenter Study 
by the Israeli Echocardiography Research Group     
901-264·A101
A Universal Time Scale of Vortex Formation Is Associated 
With Optimum Diastolic Performance of Human Hearts     
901-270·A102
Abnormal Left Ventricular Diastolic Function in Marfan 
Syndrome Demonstrated by Pulmonary Venous Inflow 
Recordings and Tissue Doppler Echocardiography     
902-262·A109
Apelin Improves Right Ventricle Contractility in Response 
to Acute Pressure Overload in Pulmonary Hypertension     
1002-30·A41
Are There Additional Benefits of Aortic Valve Replacement 
for Severe Aortic Stenosis?; Impact on LV Torsion as 
Assessed by Cardiac MRI Sponsored by the American 
Heart Association     907-281·A158
Asymptomatic Left Ventricular Diastolic Dysfunction and Risk 
of Death in the Community     1030-34·A79
Asymptomatic Left Ventricular Dysfunction Is More Prevalent 
in Pregnant Women Than in the General Population     
1023-6·A64
Automated Quantitation of Regional LV Function on Gated 
Blood Pool SPECT is Superior to Visual Assessment 
of Wall Motion When Judged vs. Cardiac MR     
908-279·A168
Cardiac Contractility Modulation Electrical Signals Normalize 
Expression of the Excitation-Contraction Coupling 
Proteins Presenillin-2 and Sorcin in Left Ventricular 
Myocardium of Dogs With Chronic Heart Failure     
1002-3·A35
Cardiac Differentiated Mesenchymal Stem Cells Protect 
Against Diastolic Dysfunction by Preventing Post-Infarct 
Remodeling     1002-22·A39
Cardiac Improvement During Mechanical Unloading in 
Idiopathic Dilated Cardiomyopathy: Criteria for Weaning 
From Left Ventricular Assist Devices     1023-24·A68
Cardiac Torsion by 4-Dimensional Speckle Imaging: Validation 
Against Sonomicrometry     902-271·A111
Chaotic Left Ventricular Diastole in Pulmonary Hypertension: 
A Tissue Doppler Study     901-267·A101
Combined Treatment With Beta Blockers and Selective 
Serotonin Reuptake Inhibitors Improves Survival 
of Patients With End-Stage Heart Failure and Major 
Depression     1009-26·A49
Comparison of Infarct Size and Cardiac Function in Patients 
With and Without Diabetes Mellitus After Primary 
Percutaneous Coronary Intervention for Acute Myocardial 
Infarction     1010-66·A194
Continuous Curvatures in a Model of the Human Cardiac 
Geometry     1036-317·A379
Early Detection of Diabetic Heart Disease by 2D Speckle 
Tracking Echocardiography     901-281·A105
Early Impairment of Myocardial Function and Large Artery 
Remodeling Are Associated With an Enhanced Left 
Ventricular Inotropic Function in Prehypertensive 
Subjects      805-8·A331
Echo Peak Pressure Index as a New Noninvasive Load-
Independent Indicator of Ventricular Recovery in Patients 
on Mechanical Circulatory Support: Association With 
Successful Device Removal      819-3·A81
Effect of Aging on Left Ventricular Dyssynchrony: Assessment 
Using Real Time Three-Dimensional Echocardiography     
902-282·A114
Effect of Aortic Stiffness on Left Ventricular Long Axis 
Systolic Function in Patients With Marfan Syndrome     
902-264·A109
Effect of Coronary Endothelial Dysfunction on Left Ventricular 
Function in Patients With Never-Treated Hypertension     
809-7·A350
EPO-Induced Neovascularization in Heart Failure Is 
Mediated Through Vascular Endothelial Growth Factor     
1002-34·A42
Exploring the Links Between Left Ventricular Diastolic 
Dysfunction and Reduced Exercise Tolerance in Newly 
Diagnosed Essential Hypertension: A Tissue Doppler 
Imaging Approach     904-278·A130
Impact of Contrast Echocardiography on Overall Cardiac 
Diagnosis and Patient Management in a Large In-Hospital 
Patient Cohort     904-256·A125
Impact of Global Afterload on Left Ventricular Myocardial 
Contractility in Asymptomatic Aortic Stenosis: A SEAS 
Substudy     1036-320·A380
Impact of Therapy on Long-Term Survival in Heart Failure 
With Preserved Systolic Function     1030-31·A78
Increased Ambulatory Arterial Stiffness Index Is Associated 
With Increase in Left Ventricular Filling Pressure During 
Exercise in Hypertensive Patients     903-275·A121
Influence of Body Mass Index on Ventricular Vascular 
Stiffening in Healthy Children     1030-38·A80
Intraventricular Blood Flow Vorticity Reflects Left Ventricular 
Diastolic Dysfunction: Quantitative Assessment by 
Contrast Echocardiography Using Vector Particle Image 
Velocitimetry     904-258·A126
Left Ventricular Diastolic Function and Mass Improve After 
Bariatric Surgery     1030-1·A72
Left Ventricular Restrictive Filling as a Predictor of Outcome 
in Patients With Cardiac Resynchronization Therapy     
901-250·A98
Left Ventricular Torsion Measured by Speckle Tracking 
Imaging is a Strong Index of Global Contractility     
905-251·A134
Left Ventricular Torsion: An Important Mechanism for 
Maintaining Normal Filling Pressures--A Speckle 
Tracking Echocardiography Study in Normal Subjects     
1030-37·A80
Load Dependence of 2D Strain Rate and Doppler Tissue 
Myocardial Velocities: Analysis During ExtrACorporeal 
Life Support     904-275·A130
LV Long-axis Dysfunction in Adult Patients With 
“Corrected” Aortic Coarctation Is Related to a Later 
Age of Intervention and Increased Aortic Stiffness     
1032-125·A96
Modulating Effect of Glycemic Control on the Left Ventricular 
Response to Afterload Stress in Diabetic Canines With 
Left Ventricular Dysfunction     1016-18·A57
Monitoring Apical Twist Alone as Compared to Torsion Is 
Adequate for Evaluating Heart Function     904-259·A126
Non-Dilated Cardiomyopathy: Clinical Characteristics, 
Left Ventricular Structure and Factors Influencing 
Improvement in Systolic Function     1016-25·A58
Non-Invasive Computerized Acoustic Cardiographic 
Prediction of Left Ventricular Systolic Dysfunction     
1033-151·A268
Preclinical Myocardial Dysfunction Is Detected by Strain/
Strain Rate Before Conventional Measures in Patients 
Undergoing Adjuvant Breast Cancer Treatment With 
Trastuzumab (Herceptin™)     905-250·A134
Preoperative Wall-Stress-Adjusted Ejection Fraction Change 
With Exercise Best Predicts Survival After Aortic Valve 
Replacement for Chronic Severe Aortic Regurgitation     
1006-96·A271
Ranolazine Attenuates Palmitoyl-L-Carnitine Induced 
Ventricular Diastolic Dysfunction     1003-47·A179
Real-Time 3-Dimensional Echocardiographic Quantification 
of Left Ventricular Volumes: Multicenter Study for 
Validation With Magnetic Resonance Imaging and 
Investigation of Sources of Error     902-270·A111
Reduced Aortic Distensibility in Early Stage Chronic Kidney 
Disease: The Precursor to Premature Cardiovascular 
Disease     907-275·A157
Reduction in Left Ventricular Systolic Longitudinal Function 
Precedes Global Impairment of Systolic Function in 
Patients With Marfan Syndrome     901-283·A105
Relation of Ventricular-Vascular Coupling to Exercise Capacity 
in Ischemic Cardiomyopathy: A Cardiac Multi-Modality 
Imaging Study     1023-38·A71
Rheumatoid Arthritis Is Independently Associated With 
Increased Left Ventricular Mass but Not Reduced Ejection 
Fraction     1023-31·A70
Right Ventricular Performance by Cardiac Magnetic Resonance 
Imaging in Patients With Pulmonary Hypertension     
1030-22·A76
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